Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Brent R. Logan PhD
Director, Professor
Department of Institute for Health and Equity
Division of Biostatistics

OFFICE ADDRESS:
Health Research Center
8701 Watertown Plank Rd
Milwaukee, WI 53226

EDUCATION:
08/1992 - 05/1996 B.S., Vanderbilt University, Nashville, TN
09/1996 - 06/1998 M.S., Northwestern University, Evanston, IL
06/1998 - 06/2001 Ph.D., Northwestern University, Evanston, IL

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
09/1996 - 06/1997 Fellowship, Department of Statistics, Northwestern University, Evanston, IL

FACULTY APPOINTMENTS:
09/1999 - 06/2001 Lecturer, Department of Statistics, Northwestern University, Evanston, IL
01/2001 - 05/2001 Lecturer,, Department of Mathematics and Computer Science, Loyola University, Chicago, IL
08/2001 - 06/2006 Assistant Professor, Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI 53226
08/2001 - 06/2006 Adjunct Assistant Professor, Department of Mathematics, University of Wisconsin-Milwaukee, Milwaukee, WI
07/2006 - 06/2011 Associate Professor,, Institute for Health & Equity, Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI 53226
07/2006 - 06/2011 Adjunct Associate Professor, Department of Mathematics, University of Wisconsin-Milwaukee, Milwaukee, WI
07/2011 - Present Professor,, Institute for Health & Equity, Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI 53226
07/2011 - Present Adjunct Professor, Department of Mathematics, University of Wisconsin-Milwaukee, Milwaukee, WI

ADMINISTRATIVE APPOINTMENTS:
04/2015 - Present Director, Institute for Health & Equity, Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI 53226

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
07/2002 - 05/2009 Course Administrator, Institute for Health & Equity, Masters of Public Health, Medical College of Wisconsin, Milwaukee, WI 53226

AWARDS AND HONORS:
08/1992 - 05/1996 Dean's Honor Scholarship, Vanderbilt University, Nashville, TN
05/1995 - Present Phi Beta Kappa
09/1996 - 06/1997 Fellowship, Department of Statistics, Northwestern University, Evanston, IL

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
01/2000 - Present American Statistical Association
01/2000 - Present International Biometric Society
01/2002 - Present Society for Clinical Trails

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Journal Review
Biometrical Journal
Statistics in Medicine
Intl Journal of Pharmaceutical Medicine
Journal of the American Statistical Association
Communications in Statistics-Theory and Methods
Bone Marrow Transplantation
Biometrics
Biometrika
Multivariate Behavioral Research
Signal Processing
Clinical Trails
Journal of Statistical Computation and Simulation

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
09/2003 - 06/2009 MCW Liaison, Milwaukee Chapter of the American Statistical Association

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
08/2001 - Present Statistician, Data Coordinating Center of the Blood and Marrow Transplant Clinical Trails Network
09/2002 - Present Statistical Consultant, National Marrow Donor Program
09/2004 - 02/2009 Statistician, Autoimmune Diseases Working Committee, Center for International Blood and Marrow Transplant Research (CIBMTR)
09/2004 - Present Statistician, Donor Health and Services Working Committee, Center forInternational Blood and Marrow Transplant Research (CIBMTR)
09/2004 - 02/2009 Statistician, Solid Tumor Working Committee, Center for International Blood and Marrow Transplant Research (CIBMTR)
09/2006 - Present Statistician, Resources for Clinical Investigations in Blood and Marrow Transplantation (RCIBMT)
09/2006 - Present Statistician, Regimen-Related Toxicity Working Committee, Center for International Blood and Marrow Transplant Research (CIBMTR)
03/2010 - 12/2013 Member, Oncologic Drug Advisory Committee, Food and Drug Administration

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
BMT Clinical Research Network Data Coordinating Center
Source:
NIH
Role:
Statistician
PI:
Horowitz
Dates:
09/30/2001 - 06/30/2022
Direct Funds:
$7,783,382
 
Title:
Stem Cell Therapeutic Outcomes Database
Source:
HRSA
Role:
Statistician
PI:
Rizzo
Dates:
09/27/2006 - 09/30/2022
Direct Funds:
$3,552,921
 
Title:
Primary Immune Deficiency Disease Treatment Consortium
Source:
NIH/University of California-San Francisco
Role:
Statistician/ Site PI
PI:
Puck
Dates:
09/01/2009 - 08/30/2023
Direct Funds:
$883,828
 
Title:
Inhibition of oral tumorigenesis by antitumor B
Source:
NIH/NCI
Role:
Statistician
PI:
You
Dates:
2017 - 2021
Direct Funds:
$2,247,454
 
Title:
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
Source:
NIH
Role:
Statistician
PI:
Pulsipher
Dates:
2017 - 2024
Direct Funds:
$1,496,945
 
Title:
A data resource for analyzing blood and marrow transplants
Source:
NIH
Role:
Statistician
PI:
Shaw
Dates:
02/2018 - 01/2023
Direct Funds:
$4,471,620
 
Title:
Immuno-oncology translation network: Cellular immunotherapy data resource (CIDR)
Source:
NIH
Role:
Statistician
PI:
Pasquini
Dates:
2019 - 2023
Direct Funds:
$8,657,691
 
Title:
Quantitative (Perfusion and Diffusion) MRI Biomarkers to Measure Glioma Response
Source:
NIH
Role:
Statistician
PI:
Schmainda
Dates:
2020 - 2024
Direct Funds:
$498,568
 
Pending
Peer Review
Title:
Machine Learning to identify Biomarkers for Risk of Chronic Graft-Versus-Host Disease
Source:
NIH/NCI
Role:
PI
PI:
Paczesny/Logan
Dates:
2021 - 2026
Direct Funds:
$506,770
 
Prior
Peer Review
Title:
Enhanced Upper Limb Motor Control by Reduced Synergistic Muscle Patterns and Spasticity after Chemodenervation
Source:
NIDRR
Role:
Statistician
PI:
McGuire
Dates:
07/01/2002 - 06/30/2005
Direct Funds:
$113,907
 
Title:
National Marrow Donor Program Service Agreement #16558
Source:
NMDP
Role:
Statistician/ PI
PI:
Logan
Dates:
09/01/2002 - 09/30/2015
Direct Funds:
$67,208
 
Title:
Statistical Methods for Comparing Several Treatment Groups in Survival Analysis
Source:
American Cancer Society/ Medical College of Wisconsin Cancer Center
Role:
PI
PI:
Logan
Dates:
01/01/2003 - 12/31/2003
Direct Funds:
$20,000
 
Title:
Development of Skin Cancer Quality of Life Instrument
Source:
NIH
Role:
Statistician
PI:
Rhee
Dates:
05/01/2004 - 04/30/2006
Direct Funds:
$136,000
 
Title:
Effect of a Pain Protocol on Discomfort in Dementia
Source:
NIH/ University of Wisconsin-Milwaukee
Role:
Statistician
PI:
Kovach
Dates:
07/01/2007 - 11/30/2011
Direct Funds:
$10,846
 
Title:
Techniques for Modeling Complet Longitudinal Studies
Source:
NIH/NCI
Role:
Co-Investigator
PI:
Klein
Dates:
09/17/2007 - 07/31/2011
Direct Funds:
$185,109
 
Title:
HSC Donor Safety and Quality of Life
Source:
NIH/ University of Utah
Role:
Statistician
PI:
Pulsipher
Dates:
12/01/2008 - 11/30/2013
Direct Funds:
$26,596
 
Title:
Dose Finding Study of Busulfan for Newly Diagnosed Infants with SCID
Source:
NIH/ Boston Children's Hospital
Role:
Statistician/ Site PI
PI:
Pai
Dates:
05/01/2014 - 04/30/2015
Direct Funds:
$156,942
 
Title:
KIR-Favorable Haploidentical Transplantation in Children
Source:
NIH/ St. Jude Children's Hospital
Role:
Statistician/ Site PI
PI:
Leung
Dates:
07/01/2014 - 06/30/2019
Direct Funds:
$258,414
 
Title:
Ensemble prediction models for personalized therapy
Source:
Advancing a Healthier Wisconsin-Research and Education Program
Role:
PI
PI:
Logan
Dates:
07/01/2015 - 06/30/2017
Direct Funds:
$98,825
 
Title:
Discontinuation of Immunosuppression (DISCIS) study
Source:
NIH
Role:
PI
PI:
Logan
Dates:
07/15/2015 - 12/30/2017
Direct Funds:
$131,776
 
Title:
Estimation of treatment effect in hematologic oncology (HO) trials in the presence of subsequent therapies
Source:
FDA
Role:
PI
PI:
Logan
Dates:
09/16/2019 - 03/15/2021
Direct Funds:
$99,999
 

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
*Logan BR and Tamhane AC, "Multiple Test Procedures for Identifying the Minimum Effective and Maximum Safe Doses of a Drug", Division of Biostatistics Seminar Series, Medical College of Wisconsin, Milwaukee, Wisconsin, - 12/2000
*Logan BR and Tamhane AC, "Multiple Test Procedures for Identifying the Minimum Effective and Maximum Safe Doses of a Drug", Department of Mathematics Seminar Series, Illinois State University, Bloomington-Normal, Illinois, - 12/2000
*Logan BR and Tamhane AC, "Multiple Test Procedures for Identifying the Minimum Effective and Maximum Safe Doses of a Drug", Division of Biostatistics Seminar Series, Tulane University, New Orleans, Louisiana, - 12/2000
*Logan BR, Zhang, MJ, and Wang H, "Pairwise Multiple Comparison Adjustment in Survival Analysis", Division of Biostatistics Seminar Series, Medical College of Wisconsin, Milwaukee, Wisconsin, - 03/2004
*Logan BR and Geliazkova MP, "An Evolution of Spatial Thresholding Procedures in fMRI Analysis", Department of Mathematics, Statistics and Computer Science Seminar Series, Marquette University, Milwaukee, Wisconsin, - 04/2006
*Logan BR, Zhang MJ, and Klein JP, "Marginal Models for Clustered Time to Event Data with Competing Risks Using Pseudo-Values", Department of Biostatistics Seminar Series, University of Wisconsin-Madison, Madison, Wisconsin, - 01/2009
*Logan BR, Zhang MJ, and Klein JP, "Marginal Models for Clustered Time to Event Data with Competing Risks Using Pseudo-Values", Department of Statistics Seminar Series, Northwestern University, Evanston, Illinois, - 11/2010
*Logan BR, "Issues in clinical trials in hematopoietic cell transplantation", Office of Oncological Drug Products, Food and Drug Administration, - 07/2009
*Logan BR, "Multiple Testing Workshop", Milwaukee Chapter of the ASA Fall Meeting, Milwaukee, Wisconsin, - 10/2009
*Logan BR, "Group sequential methods for comparing late differences in survival curves", Office of Oncological Drug Products, Food and Drug Administration, - 09/2010
*Logan BR, Zhang MJ, and Klein JP, "Marginal Models for Clustered Time to Event Data with Competing Risks Using Pseudo-Values", Division of Biostatistics Seminar Series, Medical College of Wisconsin, Milwaukee, Wisconsin, - 02/2009
* Denotes invited talks.
 
Regional
*Logan BR, Zhang MJ, and Wang H, "Pairwise Multiple Comparison Adjustment in Survival Analysis", Fall meeting of the Northeastern Illinois Chapter, American Statistical Association, Skokie, Illinois, - 10/2003
*Logan BR, Pasquini MC, Nietfeld, JJ, Verter, F, Horowitz MM, "Estimating the Lifetime Likelihood that a Person Might use Their Umbilical Cord Blood if it is Stored at Birth", Conference on Teaching Elementary Statistics, Medical College of Wisconsin, Milwaukee, Wisconsin
*Logan BR, "Pseudovalue Regression Models for Time to Event Data", Fall Meeting of the Northwestern Illinois Chapter, American Statistical Association, Skokie, Illinois, - 10/2012
 
National
*Logan, BR and Tamhane AC, "Multiple Test Procedures for Identifying the Minimum Effective and Maximum Safe Doses of a Drug", 6th Great Lakes Symposium on Applied Statistics, Kalamazoo, Michigan, - 10/2000
*Logan BR and Rowe DB, "Thresholding Methods in FMRI Analysis Using the False Discovery Rate: An Investigation into the Impact of Spatial Correlation", 2003 Human Brain Mapping Conference, New York City, New York, - 06/2003
Logan BR, Zhang MJ, and Wang H, "Pairwise Multiple Comparison Adjustment in Survival Analysis", 2003 Joint Statistical Meetings, San Francisco, California, - 08/2003
Logan, BR, Geliazkova, M. "Measuring the size of a region of activation in fMRI analysis, " 2005 Joint Statistical Meetings, Minneapolis
*Logan BR, "Getting the most out of journal articles", 2005 NMDP Council Meeting, Minneapolis, Minnesota, - 11/2005
*Logan BR and Majhail N, "Getting the most out of your journal articles", 2007 NMDP Council Meeting, Minneapolis, Minnesota, - 11/2007
*Logan BR, "Phase II and III Study Designs for aGVHD", Workshop on Clinical Trial Endpoints for Acute Graft-vs-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation, Washington, DC, - 05/2009
Logan BR and Geliazkova M, "Measuring the Size of a Region of Activation in fMRI Analysis", 2005 Joint Statistical Meetings, Minneapolis, Minnesota, - 08/2005
Logan BR, "Understanding Biomedical Statistics", American Association of Blood Banks, Webinar, - 04/2014
Logan BR and Ahn KW, "Marginal Models for Restricted Mean Survival with Clustered Time to Event Data Using Pseudo-Values", 2015 ENAR Biometrics Meeting, Miami, Florida, - 03/2015
Logan BR, "A Conditional Error Rate Approach to Adaptive Enrichment Trial Designs", 2013 ENAR Biometrics Meeting, Orlando, Florida, - 04/2013
 
International
Logan BR and Tamhane, AC "Combining global and marginal tests to compare two treatments on multiple endpoints", International Conference on Multiple Comparison Procedures, Berlin, Germany, - 06/2000
Logan BR, "Generalized Linear Mixed Models for Correlated Time to Event Data Using Pseudo-Values", International Conference on Survival Analysis in Memory of John P. Klein, Milwaukee, Wisconsin, - 06/2014
*Logan BR, "Statistical Issues in Clinical Trials", 2002 Tandem BMT Meetings, Orlando, Florida, - 02/2002
*Logan Br, "Statistical Issues in Clinical Trials", 2003 Tandem BMT Meetings, Keystone, Colorado, - 01/2003
*Logan BR, "Biological Assignment Trials in Bone Marrow Transplantation", 2003 Tandem BMT Meetings, Keystone, Colorado, - 01/2003
*Logan BR, "Clinical Research. Methodology Workshop: Design, Development, Analysis and Interpretation of Studies with Focus on Transplantation", 10th Brazilian Congress on Bone Marrow Transplantation, Curitiba, Brazil, - 08/2006
*Logan BR, "Thresholding and the Multiple Testing Problem", Human Brain Mapping Conference, Chicago, Illinois, - 06/2007
Logan BR, Geliazkova MP, Laud PW, "A Bayesian Spatial Mixture Model for fMRI Data", International Conference on Multiple Comparison Procedures, Vienna, Austria, - 07/2007
*Logan BR, "ASBMT Clinical Research Training Course.", Faculty participant and presenter, Keystone, Colorado, - 07/2007
*Logan BR, "ASBMT Clinical Research Training Course", Faculty participant and presenter, Keystone, Colorado, - 07/2008
*Logan BR, "Beyond the standard phase II clinical trial", 2009 Tandem BMT Meetings, Tampa Bay, Florida, - 02/2009
*Logan BR, "ASBMT Clinical Research Training Course", Faculty participant and presenter, Keystone, Colorado, - 07/2009
*Logan BR, "Statistical Design of Clinical Trials: How best to answer your question", 2010 Tandem BMT Meetings, Orlando, Florida, - 02/2010
*Logan BR, "Cox proportional hazards model using SAS", Short Course, 2010 Tandem BMT Meetings, Orlando, Florida, - 02/2010
*Logan BR, "ASBMT Clinical Research Training Course", Faculty participant and presenter, Keystone, Colorado, - 07/2010
*Logan BR, "Overview of bias in observational studies using registry databases" 2011 EBMT Meetings, 2011 EBMT Meetings, Paris, France, - 04/2011
Logan BR, "Long-term survival comparisons with covariate adjustment using a registry database", 2011 International Society for Clinical Biostatistics, Ottawa, California, - 08/2011
Logan BR, "Adaptive Designs in Clinical Trails", 2014 Tandem BMT Meetings, Grapevine, Texas, - 02/2014
*Logan BR, Brazauskas R, Fraser R, "Randomized Phase II Trails vs. Single Arm Phase II Trails with a Registry Control in Rare Diseases", International Chinese Statistical Association Meeting, - 06/2017
Logan BR, "Multi-State Models in BMT", 2013 Tandem BMT Meetings, Salt Lake City, Utah, - 02/2013
Logan BR, "Issues in Design and Analysis of Non-Inferiority Studies", 2012 DIA Meeting, Philadelphia, Pennsylvania, - 06/2012
Logan BR, "A cone order monotone test for the one-sided multiple endpoint problem", International Conference on Multiple Comparison Procedures, Washington D.C., - 06/2002
 

PEER REVIEWED WORKSHOPS/PRESENTATIONS:
National
Tallman M, Dewald G, Lazarus H, Gandham S, Nelson G, Logan BR, et al., Impact of Cytogenetics on Outcome of Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation for Adults with AML., Oral Presentation at American Society of Hematologists Meeting, - 12/2004
 

COMMITTEE SERVICE:
Medical College of Wisconsin
09/2001 - 09/2004 Member, Data Safety Monitoring Council, Medical College of Wisconsin
09/2001 - 08/2003 Member, Graduate Studies Council, Medical College of Wisconsin
07/2002 - 05/2009 Chair, MPH Committee, Division of Biostatistics, Medical College of Wisconsin
09/2002 - 08/2003 Seminar Chair, Division of Biostatistics, Medical College of Wisconsin
01/2003 - Present Member, Pediatric Data Safety Monitoring Board, Medical College of Wisconsin
08/2005 - 05/2008 Member, Graduate Studies Council, Medical College of Wisconsin
08/2005 - 05/2008 Chair, Newsletter Committee, Division of Biostatistics, Medical College of Wisconsin
01/2007 - 06/2010 MCW Faculty, Council Representative, Department of Population Health, Medical College of Wisconsin
09/2007 - 06/2010 Member, Nominating Committee, Graduate Studies Council, Medical College of Wisconsin
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Graduate Student Education
09/2001 - 05/2002 Statistical Models and Methods I/II
07/2002 - 05/2009 Master of Public Health, Biostatistics
09/2002 - 12/2002 Statistical Models and Methods I
09/2003 - 05/2007 Readings and Research, Maya Geliazkova
09/2003 - 12/2003 Advanced Statistics
06/2004 - 08/2005 Readings and Research, Xiaolin Fan
09/2004 - 12/2004 Readings and Research, Grace Zhang
01/2005 - 05/2005 Advanced Statistical Computing
09/2005 - 12/2005 Advanced Statistics
09/2006 - 12/2006 Clinical Trails **Denotes courses which were identified by the Course of Evaluation Committee of the Graduate School as being one of the outstanding courses offered by the Graduate School
09/2007 - 12/2007 Advanced Statistical Computing
01/2009 - 05/2009 Statistical Models and Methods II
01/2009 - 05/2009 Theory of Consulting
06/2009 - Present Readings and Research, Shuyuan Mo
06/2009 - 09/2009 Readings and Research, Franco Mendolia
09/2009 - 12/2009 Clinical Trails **Denotes courses which were identified by the Course Evaluation Committee of the Graduate School as being one of the outstanding courses offered by the Graduate School
01/2010 - 05/2010 Statistical Models and Methods II
06/2010 - 09/2010 Readings and Research, Aaron Katch
01/2012 - 05/2012 Statistical Models and Methods II
09/2012 - 12/2012 Statistical Models and Methods I
09/2013 - 12/2013 Advanced Statistics
01/2015 - 05/2015 Theory of Consulting
09/2015 - 12/2015 Advanced Statistics
 

EXTRAMURAL TEACHING:
Graduate Student Education
06/2010 - 09/2010 Medical College of Wisconin, Readings and Research, Yanzhi Wang
 

MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Graduate Students
PhD Students Advised
Xiao Li, Medical College of Wisconsin, 2020 - Present
Manoj Khanal, Medical College of Wisconsin, 2020 - Present
Yanzhi Wang, Medical College of Wisconsin, - 2014
Shuyuan Mo, Medical College of Wisconsin, - 2011
Bonifride Tuyishimire, Medical College of Wisconsin, - 2018
Michael Martens, Medical College of Wisconsin, - 2017
PhD Committees
Jingxia Liu, Medical College of Wisconsin, - 2007
Ying Zhang, Medical College of Wisconsin, - 2016
Yinghua Zhang, Medical College of Wisconsin, - 2007
Natasha Sahr, Medical College of Wisconsin, - 2018
Nick DeVogel, Medical College of Wisconsin, - 2019
Nicole Salowitz, Medical College of Wisconsin, - 2014
Lucy Lu, Medical College of Wisconsin, - 2005
Xiaolin Fan, Medical College of Wisconsin, - 2009
Ruta Bajorunaite, Medical College of Wisconsin, - 2003
Peng He, Medical College of Wisconsin, - 2013
Charley Spanbauer, Medical College of Wisconsin, - 2020
 

EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:
Graduate Students
MS Committees
Michael Weißgerber, - 2005
Angelica Delgado-Rendon, - 2008
Kenneth Yen, - 2005
Chris Meller, - 2004
Sital Bhargava, - 2007
Rachel Bercovitz, - 2015
Jennifer Knight, - 2015
Nevin Uysal, - 2003
Syed Hussain, - 2007
PhD Students Advised
Maya Geliazkova, University of Wisconsin-Milwaukee, - 2007
 
Clinical/Research Fellows
Arash Babaei, 2013 - 2015
David Gourlay, 2013 - 2015
Sarah Dobroszi, 2015 - 2017
 

PROGRAMMATIC DEVELOPMENTS:
Educational Programs
Student
Revised curriculum and course study guide for Biostatistics course in MPH distance learning program.
 
 
 
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Logan, B.R. and Tamhane, A.C.. Combining global and marginal tests to compare two treatments on multiple endpoints. Biometrical Journal. 43: 591-604, 2001.
2. Tamhane, A.C. and Logan, B.R.. Multiple test procedures for identifying the minimum effective and maximum safe doses of a drug. Journal of the American Statistical Association. 97: 293-301, 2002.
3. Nicolosi AC, West G, Markley JG, Logan B, Olinger GN. Gadolinium attenuates regional stunning in the canine heart in vivo. J Thorac Cardiovasc Surg. 2002 Jul;124(1):57-62.
4. Drobyski, W.R., Komorowski, R., Logan, B., Gendelman, M.. Role of the passive apoptotic pathway in graft-versus-host disease. Journal of Immunology. 169: 1626-1633, 2002.
5. Tamhane AC, Logan BR. Accurate critical constants for the one-sided approximate likelihood ratio test of a normal mean vector when the covariance matrix is estimated. Biometrics. 2002 Sep;58(3):650-6.
6. Chang CC, Lorek J, Sabath DE, Li Y, Chitambar CR, Logan B, Kampalath B, Cleveland RP. Expression of MUM1/IRF4 correlates with clinical outcome in patients with B-cell chronic lymphocytic leukemia. Blood. 2002 Dec 15;100(13):4671-5.
7. Logan, B.R.. A cone order monotone test for the one-sided multivariate testing problem. Statistics and Probability Letters. 63: 315-323, 2003.
8. Chang CC, Kampalath B, Schultz C, Bunyi-Teopengco E, Logan B, Eshoa C, Dincer AP, Perkins SL. Expression of p53, c-Myc, or Bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals. Arch Pathol Lab Med. 2003 Feb;127(2):208-12.
9. Chang CC, Bredeson C, Juckett M, Logan B, Keever-Taylor CA. Tumor load in patients with follicular lymphoma post stem cell transplantation may correlate with clinical course. Bone Marrow Transplant. 2003 Aug;32(3):287-91.
10. Hurley CK, Baxter Lowe LA, Logan B, Karanes C, Anasetti C, Weisdorf D, Confer DL. National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants. Biol Blood Marrow Transplant. 2003 Oct;9(10):610-5.
11. Logan, B.R. and Tamhane, A.C. . On O’Brien’s OLS and GLS tests for multiple endpoints. Recent Developments in Multiple Comparison Procedures, IMS Lecture Notes - Monograph Series . 47:76-88, 2004.
12. Gendelman, M., Hecht, T., Logan, B., Vodanovic-Jankovic, S., Komorowski, R., and Drobyski, W.R. . Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease. Journal of Immunology. 172: 3328 – 3336, 2004.
13. Lyon R, Liu XC, Thometz JG, Nelson ER, Logan B. Reproducibility of spinal back-contour measurements taken with raster stereography in adolescent idiopathic scoliosis. Am J Orthop (Belle Mead NJ). 2004 Feb;33(2):67-70.
14. Chang CC, McClintock S, Cleveland RP, Trzpuc T, Vesole DH, Logan B, Kajdacsy-Balla A, Perkins SL. Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma. Am J Surg Pathol. 2004 Apr;28(4):464-70.
15. Logan BR, Rowe DB. An evaluation of thresholding techniques in fMRI analysis. Neuroimage. 2004 May;22(1):95-108.
16. Gendelman M, Halligan N, Komorowski R, Logan B, Murphy WJ, Blazar BR, Pritchard KA Jr, Drobyski WR. Alpha phenyl-tert-butyl nitrone (PBN) protects syngeneic marrow transplant recipients from the lethal cytokine syndrome occurring after agonistic CD40 antibody administration. Blood. 2005 Jan 01;105(1):428-31.
17. Tamhane, A.C. and Logan, B.R. . A superiority-equivalence approach to one-sided tests on multiple endpoints in clinical trials. Biometrika. 91: 715-727, 2004.
18. Hari P, Logan B, Drobyski WR. Temporal discordance between graft-versus-leukemia and graft-versus-host responses: a strategy for the separation of graft-versus-leukemia/graft-versus-host reactivity? Biol Blood Marrow Transplant. 2004 Nov;10(11):743-7.
19. Lee SJ, Loberiza FR, Antin JH, Kirkpatrick T, Prokop L, Alyea EP, Cutler C, Ho VT, Richardson PG, Schlossman RL, Fisher DC, Logan B, Soiffer RJ. Routine screening for psychosocial distress following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2005 Jan;35(1):77-83.
20. Rowe DB, Logan BR. A complex way to compute fMRI activation. Neuroimage. 2004 Nov;23(3):1078-92.
21. Tamhane AC, Logan BR. Finding the maximum safe dose level for heteroscedastic data. J Biopharm Stat. 2004 Nov;14(4):843-56.
22. Rowe DB, Logan BR. Complex fMRI analysis with unrestricted phase is equivalent to a magnitude-only model. Neuroimage. 2005 Jan 15;24(2):603-6.
23. McGregor DK, Keever-Taylor CA, Bredeson C, Schur B, Vesole DH, Logan B, Chang CC. The implication of follicular lymphoma patients receiving allogeneic stem cell transplantation from donors carrying t(14;18)-positive cells. Bone Marrow Transplant. 2005 Jun;35(11):1049-54.
24. Shidham GB, Siddiqi N, Beres JA, Logan B, Nagaraja HN, Shidham SG, Piering WF. Clinical risk factors associated with bleeding after native kidney biopsy. Nephrology (Carlton). 2005 Jun;10(3):305-10.
25. Logan BR, Wang H, Zhang MJ. Pairwise multiple comparison adjustment in survival analysis. Stat Med. 2005 Aug 30;24(16):2509-23.
26. Starsky AJ, Sangani SG, McGuire JR, Logan B, Schmit BD. Reliability of biomechanical spasticity measurements at the elbow of people poststroke. Arch Phys Med Rehabil. 2005 Aug;86(8):1648-54.
27. Logan BR. Optimal two-stage randomized phase II clinical trials. Clin Trials. 2005;2(1):5-12.
28. Logan BR, Zhang MJ, Klein JP. Regression models for hazard rates versus cumulative incidence probabilities in hematopoietic cell transplantation data. Biol Blood Marrow Transplant. 2006 Jan;12(1 Suppl 1):107-12.
29. Kovach CR, Logan BR, Noonan PE, Schlidt AM, Smerz J, Simpson M, Wells T. Effects of the Serial Trial Intervention on discomfort and behavior of nursing home residents with dementia. Am J Alzheimers Dis Other Demen. 2006 Jun-Jul;21(3):147-55.
30. Rhee JS, Matthews BA, Neuburg M, Logan BR, Burzynski M, Nattinger AB. Validation of a quality-of-life instrument for patients with nonmelanoma skin cancer. Arch Facial Plast Surg. 2006 Sep-Oct;8(5):314-8. PMCID: PMC2556600
31. Nicolosi AC, Kwok CS, Logan B. Effects of gadolinium on regionally stunned myocardium: temporal considerations. J Surg Res. 2007 May 15;139(2):286-91.
32. Rhee JS, Matthews BA, Neuburg M, Logan BR, Burzynski M, Nattinger AB. The skin cancer index: clinical responsiveness and predictors of quality of life. Laryngoscope. 2007 Mar;117(3):399-405. PMCID: PMC1847346
33. Klein JP, Logan B, Harhoff M, Andersen PK. Analyzing survival curves at a fixed point in time. Stat Med. 2007 Oct 30;26(24):4505-19.
34. Gorski J, Chen X, Gendelman M, Yassai M, Krueger A, Tivol E, Logan B, Komorowski R, Vodanovic-Jankovic S, Drobyski WR. Homeostatic expansion and repertoire regeneration of donor T cells during graft versus host disease is constrained by the host environment. Blood. 2007 Jun 15;109(12):5502-10. PMCID: PMC1890817
35. Tallman MS, Dewald GW, Gandham S, Logan BR, Keating A, Lazarus HM, Litzow MR, Mehta J, Pedersen T, Pérez WS, Rowe JM, Wetzler M, Weisdorf DJ. Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission. Blood. 2007 Jul 01;110(1):409-17. PMCID: PMC1896123
36. Lazarus HM, Stiff PJ, Carreras J, Logan BR, Akard L, Bolwell BJ, Childs RW, Gale RP, Klein JP, Lill MC, Pérez WS, Stadtmauer EA, Rizzo JD. Utility of single versus tandem autotransplants for advanced testes/germ cell cancer: a center for international blood and marrow transplant research (CIBMTR) analysis. Biol Blood Marrow Transplant. 2007 Jul;13(7):778-89.
37. Giralt S, Logan B, Rizzo D, Zhang MJ, Ballen K, Emmanouilides C, Nath R, Parker P, Porter D, Sandmaier B, Waller EK, Barker J, Pavletic S, Weisdorf D. Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program. Biol Blood Marrow Transplant. 2007 Jul;13(7):844-52.
38. Eapen M, Logan BR, Confer DL, Haagenson M, Wagner JE, Weisdorf DJ, Wingard JR, Rowley SD, Stroncek D, Gee AP, Horowitz MM, Anasetti C. Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biol Blood Marrow Transplant. 2007 Dec;13(12):1461-8. PMCID: PMC2267869
39. Logan BR, Geliazkova MP, Rowe DB. An evaluation of spatial thresholding techniques in fMRI analysis. Hum Brain Mapp. 2008 Dec;29(12):1379-89. PMCID: PMC6870886
40. Bishop MR, Logan BR, Gandham S, Bolwell BJ, Cahn JY, Lazarus HM, Litzow MR, Marks DI, Wiernik PH, McCarthy PL, Russell JA, Miller CB, Sierra J, Milone G, Keating A, Loberiza FR Jr, Giralt S, Horowitz MM, Weisdorf DJ. Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research. Bone Marrow Transplant. 2008 Apr;41(7):635-42. PMCID: PMC2587442
41. Kamani N, Spellman S, Hurley CK, Barker JN, Smith FO, Oudshoorn M, Bray R, Smith A, Williams TM, Logan B, Eapen M, Anasetti C, Setterholm M, Confer DL, National Marrow Donor Program. State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants. Biol Blood Marrow Transplant. 2008 Jan;14(1):1-6.
42. Logan BR, Klein JP, Zhang MJ. Comparing treatments in the presence of crossing survival curves: an application to bone marrow transplantation. Biometrics. 2008 Sep;64(3):733-740. PMCID: PMC2754119
43. Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM. Lifetime probabilities of hematopoietic stem cell transplantation in the U.S. Biol Blood Marrow Transplant. 2008 Mar;14(3):316-22. PMCID: PMC2531159
44. Howard DH, Meltzer D, Kollman C, Maiers M, Logan B, Gragert L, Setterholm M, Horowitz MM. Use of cost-effectiveness analysis to determine inventory size for a national cord blood bank. Med Decis Making. 2008 Mar-Apr;28(2):243-53.
45. Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM. On the probability of using cord blood. Biol Blood Marrow Transplant. 2008 Jun;14(6):724-5.
46. Rhee JS, Davis-Malesevich M, Logan BR, Neuburg M, Burzynski M, Nattinger AB. Behavior modification and risk perception in patients with nonmelanoma skin cancer. WMJ. 2008 Apr;107(2):62-8. PMCID: PMC3590063
47. Liu L, Logan B, Klein JP. Inference for current leukemia free survival. Lifetime Data Anal. 2008 Dec;14(4):432-46. PMCID: PMC2715962
48. Logan BR, Nelson GO, Klein JP. Analyzing center specific outcomes in hematopoietic cell transplantation. Lifetime Data Anal. 2008 Dec;14(4):389-404. PMCID: PMC2709496
49. Logan BR, Tamhane AC. Superiority inferences on individual endpoints following noninferiority testing in clinical trials. Biom J. 2008 Oct;50(5):693-703.
50. Logan B, Leifer E, Bredeson C, Horowitz M, Ewell M, Carter S, Geller N. Use of biological assignment in hematopoietic stem cell transplantation clinical trials. Clin Trials. 2008;5(6):607-16. PMCID: PMC2671015
51. Devetten MP, Hari PN, Carreras J, Logan BR, van Besien K, Bredeson CN, Freytes CO, Gale RP, Gibson J, Giralt SA, Goldstein SC, Gupta V, Marks DI, Maziarz RT, Vose JM, Lazarus HM, Anderlini P. Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma. Biol Blood Marrow Transplant. 2009 Jan;15(1):109-17. PMCID: PMC2929570
52. Tunes da Silva G, Logan BR, Klein JP. Methods for equivalence and noninferiority testing. Biol Blood Marrow Transplant. 2009 Jan;15(1 Suppl):120-7. PMCID: PMC2701110
53. Gale RP, Eapen M, Logan B, Zhang MJ, Lazarus HM. Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants? Bone Marrow Transplant. 2009 Mar;43(6):435-46.
54. Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson MD, Kurian S, Klein JP, Horowitz MM, Confer DL. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 2009 Apr 09;113(15):3604-11. PMCID: PMC2668845
55. van Besien K, Carreras J, Bierman PJ, Logan BR, Molina A, King R, Nelson G, Fay JW, Champlin RE, Lazarus HM, Vose JM, Hari PN. Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes. Biol Blood Marrow Transplant. 2009 May;15(5):554-63. PMCID: PMC3120935
56. Alousi AM, Weisdorf DJ, Logan BR, Bolaños-Meade J, Carter S, Difronzo N, Pasquini M, Goldstein SC, Ho VT, Hayes-Lattin B, Wingard JR, Horowitz MM, Levine JE, Blood and Marrow Transplant Clinical Trials Network. Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network. Blood. 2009 Jul 16;114(3):511-7. PMCID: PMC2713466
57. Ratanatarathorn, V., Logan, B., Wang, D., Horowitz, M., Uberti, J.P., Ringden, O., Gale, R.P., Khoury, H., Arora, M., Spellman, S., Cutler, C., Antin, J., Bornhauser, M., Hale, G., Verdonck, L., Cairo, M., Gupta, V., Pavletic, S. . Prior rituximab correlated with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation (PBSCT). British Journal of Hematology. 145: 816-824.
58. Pulsipher MA, Chitphakdithai P, Logan BR, Leitman SF, Anderlini P, Klein JP, Horowitz MM, Miller JP, King RJ, Confer DL. Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose. Blood. 2009 Sep 24;114(13):2606-16. PMCID: PMC2756121
59. Curry CV, Ewton AA, Olsen RJ, Logan BR, Preti HA, Liu YC, Perkins SL, Chang CC. Prognostic impact of C-REL expression in diffuse large B-cell lymphoma. J Hematop. 2009 Mar;2(1):20-6. PMCID: PMC2713494
60. Marks DI, Ballen K, Logan BR, Wang Z, Sobocinski KA, Bacigalupo A, Burns LJ, Gupta V, Ho V, McCarthy PL, Ringdén O, Schouten HC, Seftel M, Rizzo JD. The effect of smoking on allogeneic transplant outcomes. Biol Blood Marrow Transplant. 2009 Oct;15(10):1277-87. PMCID: PMC2768519
61. Jacobson PA, Huang J, Wu J, Kim M, Logan B, Alousi A, Grimley M, Bolaños-Meade J, Ho V, Levine JE, Weisdorf D. Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network. Biol Blood Marrow Transplant. 2010 Mar;16(3):421-9. PMCID: PMC3104501
62. Schriber J, Agovi MA, Ho V, Ballen KK, Bacigalupo A, Lazarus HM, Bredeson CN, Gupta V, Maziarz RT, Hale GA, Litzow MR, Logan B, Bornhauser M, Giller RH, Isola L, Marks DI, Rizzo JD, Pasquini MC. Second unrelated donor hematopoietic cell transplantation for primary graft failure. Biol Blood Marrow Transplant. 2010 Aug;16(8):1099-106. PMCID: PMC2897953
63. Kovach CR, Logan BR, Simpson MR, Reynolds S. Factors associated with time to identify physical problems of nursing home residents with dementia. Am J Alzheimers Dis Other Demen. 2010 Jun;25(4):317-23. PMCID: PMC2884077
64. Logan BR, Zhang MJ, Klein JP. Marginal models for clustered time-to-event data with competing risks using pseudovalues. Biometrics. 2011 Mar;67(1):1-7. PMCID: PMC2902638
65. Navarro WH, Agovi MA, Logan BR, Ballen K, Bolwell BJ, Frangoul H, Gupta V, Hahn T, Ho VT, Juckett M, Lazarus HM, Litzow MR, Liesveld JL, Moreb JS, Marks DI, McCarthy PL, Pasquini MC, Rizzo JD. Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults. Biol Blood Marrow Transplant. 2010 Oct;16(10):1442-50. PMCID: PMC2933950
66. Gupta V, Tallman MS, He W, Logan BR, Copelan E, Gale RP, Khoury HJ, Klumpp T, Koreth J, Lazarus HM, Marks DI, Martino R, Rizzieri DA, Rowe JM, Sabloff M, Waller EK, DiPersio JF, Bunjes DW, Weisdorf DJ. Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. Blood. 2010 Sep 16;116(11):1839-48. PMCID: PMC3173984
67. Levine JE, Logan B, Wu J, Alousi AM, Ho V, Bolaños-Meade J, Weisdorf D, Blood and Marrow Transplant Clinical Trials Network. Graft-versus-host disease treatment: predictors of survival. Biol Blood Marrow Transplant. 2010 Dec;16(12):1693-9. PMCID: PMC2955996
68. Barker CC, Agovi MA, Logan B, Lazarus HM, Ballen KK, Gupta V, Hale GA, Frangoul H, Ho V, Rizzo JD, Pasquini MC, Regimen-Related Toxicity Writing Committee, Center for International Blood and Marrow Transplant Research. Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia. Biol Blood Marrow Transplant. 2011 May;17(5):737-44. PMCID: PMC3035737
69. Sabloff M, Chandy M, Wang Z, Logan BR, Ghavamzadeh A, Li CK, Irfan SM, Bredeson CN, Cowan MJ, Gale RP, Hale GA, Horan J, Hongeng S, Eapen M, Walters MC. HLA-matched sibling bone marrow transplantation for β-thalassemia major. Blood. 2011 Feb 03;117(5):1745-50. PMCID: PMC3056598
70. Horan JT, Logan BR, Agovi-Johnson MA, Lazarus HM, Bacigalupo AA, Ballen KK, Bredeson CN, Carabasi MH, Gupta V, Hale GA, Khoury HJ, Juckett MB, Litzow MR, Martino R, McCarthy PL, Smith FO, Rizzo JD, Pasquini MC. Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? J Clin Oncol. 2011 Mar 01;29(7):805-13. PMCID: PMC3068057
71. Kovach CR, Woods DL, Logan BR, Raff H. Diurnal variation of cortisol in people with dementia: relationship to cognition and illness burden. Am J Alzheimers Dis Other Demen. 2011 Mar;26(2):145-50. PMCID: PMC3060946
72. Kovach CR, Logan BR, Joosse LL, Noonan PE. Failure to identify behavioral symptoms of people with dementia and the need for follow-up physical assessment. Res Gerontol Nurs. 2012 Apr;5(2):89-93. PMCID: PMC3161167
73. Krishnan A, Pasquini MC, Logan B, Stadtmauer EA, Vesole DH, Alyea E 3rd, Antin JH, Comenzo R, Goodman S, Hari P, Laport G, Qazilbash MH, Rowley S, Sahebi F, Somlo G, Vogl DT, Weisdorf D, Ewell M, Wu J, Geller NL, Horowitz MM, Giralt S, Maloney DG, Blood Marrow Transplant Clinical Trials Network (BMT CTN). Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial. Lancet Oncol. 2011 Dec;12(13):1195-203. PMCID: PMC3611089
74. Kamani NR, Walters MC, Carter S, Aquino V, Brochstein JA, Chaudhury S, Eapen M, Freed BM, Grimley M, Levine JE, Logan B, Moore T, Panepinto J, Parikh S, Pulsipher MA, Sande J, Schultz KR, Spellman S, Shenoy S. Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biol Blood Marrow Transplant. 2012 Aug;18(8):1265-72. PMCID: PMC3618440
75. Levine JE, Logan BR, Wu J, Alousi AM, Bolaños-Meade J, Ferrara JL, Ho VT, Weisdorf DJ, Paczesny S. Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study. Blood. 2012 Apr 19;119(16):3854-60. PMCID: PMC3335389
76. Zhang MJ, Davies SM, Camitta BM, Logan B, Tiedemann K, Eapen M, Thiel EL. Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia. Biol Blood Marrow Transplant. 2012 Aug;18(8):1204-10. PMCID: PMC3890239
77. Spellman SR, Eapen M, Logan BR, Mueller C, Rubinstein P, Setterholm MI, Woolfrey AE, Horowitz MM, Confer DL, Hurley CK, National Marrow Donor Program, Center for International Blood and Marrow Transplant Research. A perspective on the selection of unrelated donors and cord blood units for transplantation. Blood. 2012 Jul 12;120(2):259-65. PMCID: PMC3398760
78. Logan BR, Zhang MJ. The use of group sequential designs with common competing risks tests. Stat Med. 2013 Mar 15;32(6):899-913. PMCID: PMC3574186
79. Kovach CR, Simpson MR, Joosse L, Logan BR, Noonan PE, Reynolds SA, Woods DL, Raff H. Comparison of the effectiveness of two protocols for treating nursing home residents with advanced dementia. Res Gerontol Nurs. 2012 Oct;5(4):251-63. PMCID: PMC3475742
80. Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S, Ehninger G, Johnston L, Maziarz RT, Pulsipher MA, Porter DL, Mineishi S, McCarty JM, Khan SP, Anderlini P, Bensinger WI, Leitman SF, Rowley SD, Bredeson C, Carter SL, Horowitz MM, Confer DL, Blood and Marrow Transplant Clinical Trials Network. Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med. 2012 Oct 18;367(16):1487-96. PMCID: PMC3816375
81. Logan BR. Review of multistate models in hematopoietic cell transplantation studies. Biol Blood Marrow Transplant. 2013 Jan;19(1 Suppl):S84-7. PMCID: PMC3867133
82. Pulsipher MA, Chitphakdithai P, Logan BR, Shaw BE, Wingard JR, Lazarus HM, Waller EK, Seftel M, Stroncek DF, Lopez AM, Maharaj D, Hematti P, O'Donnell PV, Loren AW, Leitman SF, Anderlini P, Goldstein SC, Levine JE, Navarro WH, Miller JP, Confer DL. Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program. Blood. 2013 Jan 03;121(1):197-206. PMCID: PMC3538330
83. Akpek G, Pasquini MC, Logan B, Agovi MA, Lazarus HM, Marks DI, Bornhaeüser M, Ringdén O, Maziarz RT, Gupta V, Popat U, Maharaj D, Bolwell BJ, Rizzo JD, Ballen KK, Cooke KR, McCarthy PL, Ho VT. Effects of spleen status on early outcomes after hematopoietic cell transplantation. Bone Marrow Transplant. 2013 Jun;48(6):825-31. PMCID: PMC3606905
84. Bolaños-Meade J, Wu J, Logan BR, Levine JE, Ho VT, Alousi AM, Weisdorf DJ, Luznik L, Blood and Marrow Transplant Clinical Trials Network. Lymphocyte phenotype during therapy for acute graft-versus-host disease: a brief report from BMT-CTN 0302. Biol Blood Marrow Transplant. 2013 Mar;19(3):481-5. PMCID: PMC3653300
85. Anasetti C, Logan BR, Confer DL, Blood and Marrow Transplant Clinical Trials Network. Peripheral-blood versus bone marrow stem cells. N Engl J Med. 2013 01 17;368(3):288.
86. Foran JM, Pavletic SZ, Logan BR, Agovi-Johnson MA, Pérez WS, Bolwell BJ, Bornhäuser M, Bredeson CN, Cairo MS, Camitta BM, Copelan EA, Dehn J, Gale RP, George B, Gupta V, Hale GA, Lazarus HM, Litzow MR, Maharaj D, Marks DI, Martino R, Maziarz RT, Rowe JM, Rowlings PA, Savani BN, Savoie ML, Szer J, Waller EK, Wiernik PH, Weisdorf DJ. Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation research. Biol Blood Marrow Transplant. 2013 Jul;19(7):1102-8. PMCID: PMC3691352
87. Dvorak CC, Cowan MJ, Logan BR, Notarangelo LD, Griffith LM, Puck JM, Kohn DB, Shearer WT, O'Reilly RJ, Fleisher TA, Pai SY, Hanson IC, Pulsipher MA, Fuleihan R, Filipovich A, Goldman F, Kapoor N, Small T, Smith A, Chan KW, Cuvelier G, Heimall J, Knutsen A, Loechelt B, Moore T, Buckley RH. The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901. J Clin Immunol. 2013 Oct;33(7):1156-64. PMCID: PMC3784642
88. Griffith LM, Cowan MJ, Notarangelo LD, Kohn DB, Puck JM, Pai SY, Ballard B, Bauer SC, Bleesing JJ, Boyle M, Brower A, Buckley RH, van der Burg M, Burroughs LM, Candotti F, Cant AJ, Chatila T, Cunningham-Rundles C, Dinauer MC, Dvorak CC, Filipovich AH, Fleisher TA, Bobby Gaspar H, Gungor T, Haddad E, Hovermale E, Huang F, Hurley A, Hurley M, Iyengar S, Kang EM, Logan BR, Long-Boyle JR, Malech HL, McGhee SA, Modell F, Modell V, Ochs HD, O'Reilly RJ, Parkman R, Rawlings DJ, Routes JM, Shearer WT, Small TN, Smith H, Sullivan KE, Szabolcs P, Thrasher A, Torgerson TR, Veys P, Weinberg K, Zuniga-Pflucker JC, workshop participants. Primary Immune Deficiency Treatment Consortium (PIDTC) report. J Allergy Clin Immunol. 2014 Feb;133(2):335-47. PMCID: PMC3960312
89. Kovach CR, Woods DL, Devine EC, Logan BR, Raff H. Biobehavioral measures as outcomes: a cautionary tale. Res Gerontol Nurs. 2014 Mar-Apr;7(2):56-65. PMCID: PMC3965632
90. Shearer WT, Dunn E, Notarangelo LD, Dvorak CC, Puck JM, Logan BR, Griffith LM, Kohn DB, O'Reilly RJ, Fleisher TA, Pai SY, Martinez CA, Buckley RH, Cowan MJ. Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. J Allergy Clin Immunol. 2014 Apr;133(4):1092-8. PMCID: PMC3972266
91. Yanik GA, Horowitz MM, Weisdorf DJ, Logan BR, Ho VT, Soiffer RJ, Carter SL, Wu J, Wingard JR, Difronzo NL, Ferrara JL, Giralt S, Madtes DK, Drexler R, White ES, Cooke KR. Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network protocol. Biol Blood Marrow Transplant. 2014 Jun;20(6):858-64. PMCID: PMC4128626
92. Pulsipher MA, Chitphakdithai P, Logan BR, Navarro WH, Levine JE, Miller JP, Shaw BE, O'Donnell PV, Majhail NS, Confer DL. Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation. Blood. 2014 Jun 05;123(23):3655-63. PMCID: PMC4047500
93. Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio ME, Maziarz RT, Antin JH, Soiffer RJ, Weisdorf DJ, Rizzo JD, Horowitz MM, Saber W. Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. Blood. 2014 Jun 05;123(23):3664-71. PMCID: PMC4047501
94. Alsina M, Becker PS, Zhong X, Adams A, Hari P, Rowley S, Stadtmauer EA, Vesole DH, Logan B, Weisdorf D, Qazilbash M, Popplewell LL, McClune B, Bensinger W, Riches M, Giralt SA, Pasquini MC, Resource for Clinical Investigation in Blood and Marrow Transplantation. Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2014 Aug;20(8):1183-9. PMCID: PMC5036168
95. Jacobsen PB, Le-Rademacher J, Jim H, Syrjala K, Wingard JR, Logan B, Wu J, Majhail NS, Wood W, Rizzo JD, Geller NL, Kitko C, Faber E, Abidi MH, Slater S, Horowitz MM, Lee SJ. Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902. Biol Blood Marrow Transplant. 2014 Oct;20(10):1530-6. PMCID: PMC4163109
96. Saber W, Le Rademacher J, Sekeres M, Logan B, Lewis M, Mendizabal A, Leifer E, Appelbaum FR, Horowitz MM, Nakamura R, Cutler CS. Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 study rationale, design, and methods. Biol Blood Marrow Transplant. 2014 Oct;20(10):1566-72. PMCID: PMC4169902
97. Cutler C, Logan B, Nakamura R, Johnston L, Choi S, Porter D, Hogan WJ, Pasquini M, MacMillan ML, Hsu JW, Waller EK, Grupp S, McCarthy P, Wu J, Hu ZH, Carter SL, Horowitz MM, Antin JH. Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT. Blood. 2014 Aug 21;124(8):1372-7. PMCID: PMC4141519
98. Waller EK, Logan BR, Harris WA, Devine SM, Porter DL, Mineishi S, McCarty JM, Gonzalez CE, Spitzer TR, Krijanovski OI, Linenberger ML, Woolfrey A, Howard A, Wu J, Confer DL, Anasetti C. Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201. J Clin Oncol. 2014 Aug 01;32(22):2365-72. PMCID: PMC4180368
99. Logan BR, Mo S. Group sequential tests for long-term survival comparisons. Lifetime Data Anal. 2015 Apr;21(2):218-40. PMCID: PMC4305035
100. Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, Kapoor N, Hanson IC, Filipovich AH, Jyonouchi S, Sullivan KE, Small TN, Burroughs L, Skoda-Smith S, Haight AE, Grizzle A, Pulsipher MA, Chan KW, Fuleihan RL, Haddad E, Loechelt B, Aquino VM, Gillio A, Davis J, Knutsen A, Smith AR, Moore TB, Schroeder ML, Goldman FD, Connelly JA, Porteus MH, Xiang Q, Shearer WT, Fleisher TA, Kohn DB, Puck JM, Notarangelo LD, Cowan MJ, O'Reilly RJ. Transplantation outcomes for severe combined immunodeficiency, 2000-2009. N Engl J Med. 2014 Jul 31;371(5):434-46. PMCID: PMC4183064
101. Bolaños-Meade J, Logan BR, Alousi AM, Antin JH, Barowski K, Carter SL, Goldstein SC, Hexner EO, Horowitz MM, Lee SJ, Levine JE, MacMillan ML, Martin PJ, Mendizabal AM, Nakamura R, Pasquini MC, Weisdorf DJ, Westervelt P, Ho VT. Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802. Blood. 2014 Nov 20;124(22):3221-7; quiz 3335. PMCID: PMC4239331
102. Eapen M, Logan BR, Appelbaum FR, Antin JH, Anasetti C, Couriel DR, Chen J, Maziarz RT, McCarthy PL, Nakamura R, Ratanatharathorn V, Vij R, Champlin RE. Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy. Biol Blood Marrow Transplant. 2015 Jan;21(1):55-9. PMCID: PMC4272909
103. Barker JN, Fei M, Karanes C, Horwitz M, Devine S, Kindwall-Keller TL, Holter J, Adams A, Logan B, Navarro WH, Riches M, RCI BMT 05-DCB Protocol Team. Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia. Br J Haematol. 2015 Feb;168(3):405-12. PMCID: PMC5557396
104. Hsu JW, Wingard JR, Logan BR, Chitphakdithai P, Akpek G, Anderlini P, Artz AS, Bredeson C, Goldstein S, Hale G, Hematti P, Joshi S, Kamble RT, Lazarus HM, O'Donnell PV, Pulsipher MA, Savani BN, Schears RM, Shaw BE, Confer DL. Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis. Biol Blood Marrow Transplant. 2015 Jan;21(1):165-71. PMCID: PMC4272878
105. Hong S, Le-Rademacher J, Artz A, McCarthy PL, Logan BR, Pasquini MC. Comparison of non-myeloablative conditioning regimens for lymphoproliferative disorders. Bone Marrow Transplant. 2015 Mar;50(3):367-74. PMCID: PMC4351124
106. Appelbaum FR, Anasetti C, Antin JH, Atkins H, Davies S, Devine S, Giralt S, Heslop H, Laport G, Lee SJ, Logan B, Pasquini M, Pulsipher M, Stadtmauer E, Wingard JR, Horowitz MM. Blood and marrow transplant clinical trials network state of the Science Symposium 2014. Biol Blood Marrow Transplant. 2015 Feb;21(2):202-24. PMCID: PMC4426907
107. Bejanyan N, Weisdorf DJ, Logan BR, Wang HL, Devine SM, de Lima M, Bunjes DW, Zhang MJ. Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research study. Biol Blood Marrow Transplant. 2015 Mar;21(3):454-9. PMCID: PMC4329076
108. Majhail NS, Chitphakdithai P, Logan B, King R, Devine S, Rossmann SN, Hale G, Hartzman RJ, Karanes C, Laport GG, Nemecek E, Snyder EL, Switzer GE, Miller J, Navarro W, Confer DL, Levine JE. Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era. Biol Blood Marrow Transplant. 2015 Jan;21(1):142-50. PMCID: PMC4272902
109. Eapen M, Logan BR, Horowitz MM, Zhong X, Perales MA, Lee SJ, Rocha V, Soiffer RJ, Champlin RE. Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation. J Clin Oncol. 2015 Feb 01;33(4):364-9. PMCID: PMC4302216
110. Ballen KK, Logan BR, Laughlin MJ, He W, Ambruso DR, Armitage SE, Beddard RL, Bhatla D, Hwang WY, Kiss JE, Koegler G, Kurtzberg J, Nagler A, Oh D, Petz LD, Price TH, Quinones RR, Ratanatharathorn V, Rizzo JD, Sazama K, Scaradavou A, Schuster MW, Sender LS, Shpall EJ, Spellman SR, Sutton M, Weitekamp LA, Wingard JR, Eapen M. Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation. Biol Blood Marrow Transplant. 2015 Apr;21(4):688-95. PMCID: PMC4359657
111. Logan AC, Wang Z, Alimoghaddam K, Wong RM, Lai T, Negrin RS, Grumet C, Logan BR, Zhang MJ, Spellman SR, Lee SJ, Miklos DB, Center for International Blood and Marrow Transplantation. ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2015 Apr;21(4):746-54. PMCID: PMC4363312
112. Chen YB, Lane AA, Logan B, Zhu X, Akpek G, Aljurf M, Artz A, Bredeson CN, Cooke KR, Ho VT, Lazarus HM, Olsson R, Saber W, McCarthy P, Pasquini MC. Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2015 Jun;21(6):1046-1053. PMCID: PMC4426014
113. Olsson RF, Logan BR, Chaudhury S, Zhu X, Akpek G, Bolwell BJ, Bredeson CN, Dvorak CC, Gupta V, Ho VT, Lazarus HM, Marks DI, Ringdén OT, Pasquini MC, Schriber JR, Cooke KR. Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. Leukemia. 2015 Aug;29(8):1754-62. PMCID: PMC4527886
114. Majhail NS, Mau LW, Chitphakdithai P, Payton T, Eckrich M, Joffe S, Lee SJ, LeMaistre CF, LeRademacher J, Loberiza F, Logan B, Parsons SK, Repaczki-Jones R, Robinett P, Rizzo JD, Murphy E, Denzen EM. National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care Delivery. Biol Blood Marrow Transplant. 2015 Jul;21(7):1308-14. PMCID: PMC4466059
115. Sorror ML, Logan BR, Zhu X, Rizzo JD, Cooke KR, McCarthy PL, Ho VT, Horowitz MM, Pasquini MC. Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study. Biol Blood Marrow Transplant. 2015 Aug;21(8):1479-87. PMCID: PMC4512746
116. Shaw BE, Logan BR, Kiefer DM, Chitphakdithai P, Pedersen TL, Abdel-Azim H, Abidi MH, Akpek G, Diaz MA, Artz AS, Dandoy C, Gajewski JL, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Majhail NS, O'Donnell PV, Olsson RF, Savani BN, Schears RM, Stroncek DF, Switzer GE, Williams EP, Wingard JR, Wirk BM, Confer DL, Pulsipher MA. Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers. Biol Blood Marrow Transplant. 2015 Oct;21(10):1830-8. PMCID: PMC4568129
117. Knight JM, Rizzo JD, Logan BR, Wang T, Arevalo JM, Ma J, Cole SW. Low Socioeconomic Status, Adverse Gene Expression Profiles, and Clinical Outcomes in Hematopoietic Stem Cell Transplant Recipients. Clin Cancer Res. 2016 Jan 01;22(1):69-78. PMCID: PMC4703514
118. Young JH, Logan BR, Wu J, Wingard JR, Weisdorf DJ, Mudrick C, Knust K, Horowitz MM, Confer DL, Dubberke ER, Pergam SA, Marty FM, Strasfeld LM, Brown JWM, Langston AA, Schuster MG, Kaul DR, Martin SI, Anasetti C, Blood and Marrow Transplant Clinical Trials Network Trial 0201. Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors. Biol Blood Marrow Transplant. 2016 Feb;22(2):359-370. PMCID: PMC4716871
119. Anthias C, Shaw BE, Kiefer DM, Liesveld JL, Yared J, Kamble RT, D'Souza A, Hematti P, Seftel MD, Norkin M, DeFilipp Z, Kasow KA, Abidi MH, Savani BN, Shah NN, Anderlini P, Diaz MA, Malone AK, Halter JP, Lazarus HM, Logan BR, Switzer GE, Pulsipher MA, Confer DL, O'Donnell PV. Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers. Biol Blood Marrow Transplant. 2016 Mar;22(3):520-7. PMCID: PMC4760616
120. Anthias C, O'Donnell PV, Kiefer DM, Yared J, Norkin M, Anderlini P, Savani BN, Diaz MA, Bitan M, Halter JP, Logan BR, Switzer GE, Pulsipher MA, Confer DL, Shaw BE. European Group for Blood and Marrow Transplantation Centers with FACT-JACIE Accreditation Have Significantly Better Compliance with Related Donor Care Standards. Biol Blood Marrow Transplant. 2016 Mar;22(3):514-9. PMCID: PMC4760354
121. Brazauskas R, Logan BR. Observational Studies: Matching or Regression? Biol Blood Marrow Transplant. 2016 Mar;22(3):557-63. PMCID: PMC4756459
122. Sparapani RA, Logan BR, McCulloch RE, Laud PW. Nonparametric survival analysis using Bayesian Additive Regression Trees (BART). Stat Med. 2016 07 20;35(16):2741-53. PMCID: PMC4899272
123. Burns LJ, Logan BR, Chitphakdithai P, Miller JP, Drexler R, Spellman S, Switzer GE, Wingard JR, Anasetti C, Confer DL, Blood and Marrow Transplant Clinical Trials Network. Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201. Biol Blood Marrow Transplant. 2016 06;22(6):1108-1116. PMCID: PMC4867293
124. Laport GG, Wu J, Logan B, Bachanova V, Hosing C, Fenske T, Longo W, Devine SM, Nademanee A, Gersten I, Horowitz M, Lazarus HM, Riches ML, Blood and Marrow Transplant Clinical Trials Network. Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Network. Biol Blood Marrow Transplant. 2016 08;22(8):1440-1448. PMCID: PMC4949103
125. Ahn KW, Logan BR. PSEUDO-VALUE APPROACH FOR CONDITIONAL QUANTILE RESIDUAL LIFETIME ANALYSIS FOR CLUSTERED SURVIVAL AND COMPETING RISKS DATA WITH APPLICATIONS TO BONE MARROW TRANSPLANT DATA. Ann Appl Stat. 2016 Jun;10(2):618-637. PMCID: PMC5656291
126. D'Souza A, Pasquini M, Logan B, Giralt S, Krishnan A, Antin J, Howard A, Goodman S, Qazilbash M, Knust K, Sahebi F, Weisdorf D, Vesole D, Stadtmauer E, Maloney D, Hari P. Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study. Br J Haematol. 2017 09;178(5):816-819. PMCID: PMC5154782
127. Magenau J, Westervelt P, Khaled S, McGuirk J, Hari P, Eapen M, Becker PS, Parkin B, Braun T, Logan B, Wang H, Jagasia M, Rowley SD, Kim DD, Schechter T, Frey N, Scott B, Churay T, Lieland S, Forman S, Mineishi S. A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2017 Jan;52(1):59-65. PMCID: PMC5215562
128. Belle L, Agle K, Zhou V, Yin-Yuan C, Komorowski R, Eastwood D, Logan B, Sun J, Ghilardi N, Cua D, Williams CB, Gaignage M, Marillier R, van Snick J, Drobyski WR. Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression. Blood. 2016 10 20;128(16):2068-2082. PMCID: PMC5073185
129. O'Donnell PV, Eapen M, Horowitz MM, Logan BR, DiGilio A, Brunstein C, Fuchs EJ, Flowers ME, Salit R, Raj K, Pagliuca A, Bradstock K, Granata A, Castagna L, Furst S, Blaise D. Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis. Bone Marrow Transplant. 2016 12;51(12):1599-1601. PMCID: PMC5143194
130. Lee SJ, Logan B, Westervelt P, Cutler C, Woolfrey A, Khan SP, Waller EK, Maziarz RT, Wu J, Shaw BE, Confer D, Horowitz MM, Anasetti C. Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial. JAMA Oncol. 2016 Dec 01;2(12):1583-1589. PMCID: PMC5145732
131. Knight JM, Syrjala KL, Majhail NS, Martens M, Le-Rademacher J, Logan BR, Lee SJ, Jacobsen PB, Wood WA, Jim HSL, Wingard JR, Horowitz MM, Abidi MH, Fei M, Rawls L, Rizzo JD. Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial. Biol Blood Marrow Transplant. 2016 12;22(12):2256-2263. PMCID: PMC5116244
132. Shenoy S, Eapen M, Panepinto JA, Logan BR, Wu J, Abraham A, Brochstein J, Chaudhury S, Godder K, Haight AE, Kasow KA, Leung K, Andreansky M, Bhatia M, Dalal J, Haines H, Jaroscak J, Lazarus HM, Levine JE, Krishnamurti L, Margolis D, Megason GC, Yu LC, Pulsipher MA, Gersten I, DiFronzo N, Horowitz MM, Walters MC, Kamani N. A trial of unrelated donor marrow transplantation for children with severe sickle cell disease. Blood. 2016 11 24;128(21):2561-2567. PMCID: PMC5123194
133. Wingard JR, Wood WA, Martens M, Le-Rademacher J, Logan B, Knight JM, Jacobsen PB, Jim H, Majhail NS, Syrjala K, Rizzo JD, Lee SJ. Pretransplantation Exercise and Hematopoietic Cell Transplantation Survival: A Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902). Biol Blood Marrow Transplant. 2017 01;23(1):161-164. PMCID: PMC5182134
134. Artz AS, Logan B, Zhu X, Akpek G, Bufarull RM, Gupta V, Lazarus HM, Litzow M, Loren A, Majhail NS, Maziarz RT, McCarthy P, Popat U, Saber W, Spellman S, Ringden O, Wickrema A, Pasquini MC, Cooke KR, from the Center for International Blood and Marrow Transplantation Research. The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes. Haematologica. 2016 11;101(11):1426-1433. PMCID: PMC5394859
135. Abu Zaid M, Wu J, Wu C, Logan BR, Yu J, Cutler C, Antin JH, Paczesny S, Choi SW. Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT. Blood. 2017 01 12;129(2):162-170. PMCID: PMC5234220
136. Scott BL, Pasquini MC, Logan BR, Wu J, Devine SM, Porter DL, Maziarz RT, Warlick ED, Fernandez HF, Alyea EP, Hamadani M, Bashey A, Giralt S, Geller NL, Leifer E, Le-Rademacher J, Mendizabal AM, Horowitz MM, Deeg HJ, Horwitz ME. Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes. J Clin Oncol. 2017 Apr 10;35(11):1154-1161. PMCID: PMC5455603
137. Krakow EF, Hemmer M, Wang T, Logan B, Arora M, Spellman S, Couriel D, Alousi A, Pidala J, Last M, Lachance S, Moodie EEM. Tools for the Precision Medicine Era: How to Develop Highly Personalized Treatment Recommendations From Cohort and Registry Data Using Q-Learning. Am J Epidemiol. 2017 07 15;186(2):160-172. PMCID: PMC6664807
138. Liu Y, Logan B, Liu N, Xu Z, Tang J, Wang Y. Deep Reinforcement Learning for Dynamic Treatment Regimes on Medical Registry Data Proceedings - 2017 IEEE International Conference on Healthcare Informatics, ICHI 2017. 8 September 2017:380-385.
139. Stroncek DF, Shaw BE, Logan BR, Kiefer DM, Savani BN, Anderlini P, Bredeson CN, Hematti P, Ganguly S, Diaz MA, Abdel-Azim H, Ahmed I, Maharaj D, Seftel M, Beitinjaneh A, Seo S, Yared JA, Halter J, O'Donnell PV, Hale GA, DeFilipp Z, Lazarus H, Liesveld JL, Zhou Z, Munshi P, Olsson RF, Kasow KA, Szer J, Switzer GE, Chitphakdithai P, Shah N, Confer DL, Pulsipher MA. Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34<sup>+</sup> Yields Are Less. Biol Blood Marrow Transplant. 2018 01;24(1):175-184. PMCID: PMC5743544
140. Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Griffith LM, Puck JM, Kohn DB, Pulsipher MA, Parikh S, Martinez C, Kapoor N, O'Reilly R, Boyer M, Pai SY, Goldman F, Burroughs L, Chandra S, Kletzel M, Thakar M, Connelly J, Cuvelier G, Davila Saldana BJ, Shereck E, Knutsen A, Sullivan KE, DeSantes K, Gillio A, Haddad E, Petrovic A, Quigg T, Smith AR, Stenger E, Yin Z, Shearer WT, Fleisher T, Buckley RH, Dvorak CC. Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study. Blood. 2017 12 21;130(25):2718-2727. PMCID: PMC5746165
141. Logan BR, Sparapani R, McCulloch RE, Laud PW. Decision making and uncertainty quantification for individualized treatments using Bayesian Additive Regression Trees. Stat Methods Med Res. 2019 04;28(4):1079-1093. PMCID: PMC6028324
142. Mangurian C, Scalchunes C, Yoo J, Logan B, Henderson T, Iyengar S, Smith H, Cowan MJ. Psychosocial services for primary immunodeficiency disorder families during hematopoietic cell transplantation: A descriptive study Palliative and Supportive Care. 2018.
143. Pasquini MC, Logan B, Jones RJ, Alousi AM, Appelbaum FR, Bolaños-Meade J, Flowers MED, Giralt S, Horowitz MM, Jacobsohn D, Koreth J, Levine JE, Luznik L, Maziarz R, Mendizabal A, Pavletic S, Perales MA, Porter D, Reshef R, Weisdorf D, Antin JH. Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials. Biol Blood Marrow Transplant. 2018 06;24(6):1274-1280. PMCID: PMC5993573
144. Shaw BE, Logan BR, Spellman SR, Marsh SGE, Robinson J, Pidala J, Hurley C, Barker J, Maiers M, Dehn J, Wang H, Haagenson M, Porter D, Petersdorf EW, Woolfrey A, Horowitz MM, Verneris M, Hsu KC, Fleischhauer K, Lee SJ. Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most. Biol Blood Marrow Transplant. 2018 05;24(5):1049-1056. PMCID: PMC5953795
145. Martens MJ, Logan BR. A group sequential test for treatment effect based on the Fine-Gray model. Biometrics. 2018 09;74(3):1006-1013. PMCID: PMC6146968
146. Miggelbrink AM, Logan BR, Buckley RH, Parrott RE, Dvorak CC, Kapoor N, Abdel-Azim H, Prockop SE, Shyr D, Decaluwe H, Hanson IC, Gillio A, Dávila Saldaña BJ, Eibel H, Hopkins G, Walter JE, Whangbo JS, Kohn DB, Puck JM, Cowan MJ, Griffith LM, Haddad E, O'Reilly RJ, Notarangelo LD, Pai SY. B-cell differentiation and IL-21 response in <i>IL2RG/JAK3</i> SCID patients after hematopoietic stem cell transplantation. Blood. 2018 06 28;131(26):2967-2977. PMCID: PMC6024640
147. Moodie EEM, Stephens DA, Alam S, Zhang MJ, Logan B, Arora M, Spellman S, Krakow EF. A cure-rate model for Q-learning: Estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patients. Biom J. 2019 03;61(2):442-453. PMCID: PMC6239975
148. Schmainda KM, Prah MA, Rand SD, Liu Y, Logan B, Muzi M, Rane SD, Da X, Yen YF, Kalpathy-Cramer J, Chenevert TL, Hoff B, Ross B, Cao Y, Aryal MP, Erickson B, Korfiatis P, Dondlinger T, Bell L, Hu L, Kinahan PE, Quarles CC. Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative Project. AJNR Am J Neuroradiol. 2018 06;39(6):1008-1016. PMCID: PMC6002911
149. Knight JM, Kerswill SA, Hari P, Cole SW, Logan BR, D'Souza A, Shah NN, Horowitz MM, Stolley MR, Sloan EK, Giles KE, Costanzo ES, Hamadani M, Chhabra S, Dhakal B, Rizzo JD. Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation. BMC Cancer. 2018 May 24;18(1):593. PMCID: PMC5968588
150. Jacobsohn DA, Loken MR, Fei M, Adams A, Brodersen LE, Logan BR, Ahn KW, Shaw BE, Kletzel M, Olszewski M, Khan S, Meshinchi S, Keating A, Harris A, Teira P, Duerst RE, Margossian SP, Martin PL, Petrovic A, Dvorak CC, Nemecek ER, Boyer MW, Chen AR, Davis JH, Shenoy S, Savasan S, Hudspeth MP, Adams RH, Lewis VA, Kheradpour A, Kasow KA, Gillio AP, Haight AE, Bhatia M, Bambach BJ, Haines HL, Quigg TC, Greiner RJ, Talano JM, Delgado DC, Cheerva A, Gowda M, Ahuja S, Ozkaynak M, Mitchell D, Schultz KR, Fry TJ, Loeb DM, Pulsipher MA. Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression. Biol Blood Marrow Transplant. 2018 10;24(10):2040-2046. PMCID: PMC6239928
151. Carpenter PA, Logan BR, Lee SJ, Weisdorf DJ, Johnston L, Costa LJ, Kitko CL, Bolaños-Meade J, Sarantopoulos S, Alousi AM, Abhyankar S, Waller EK, Mendizabal A, Zhu J, O'Brien KA, Lazaryan A, Wu J, Nemecek ER, Pavletic SZ, Cutler CS, Horowitz MM, Arora M, BMT CTN.. A phase II/III randomized, multicenter trial of prednisone/sirolimus <i>versus</i> prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-<i>versus</i>-host disease: BMT CTN 0801. Haematologica. 2018 11;103(11):1915-1924. PMCID: PMC6278959
152. Wang Y, Logan BR. Testing for center effects on survival and competing risks outcomes using pseudo-value regression. Lifetime Data Anal. 2019 04;25(2):206-228. PMCID: PMC6320737
153. Haddad E, Logan BR, Griffith LM, Buckley RH, Parrott RE, Prockop SE, Small TN, Chaisson J, Dvorak CC, Murnane M, Kapoor N, Abdel-Azim H, Hanson IC, Martinez C, Bleesing JJH, Chandra S, Smith AR, Cavanaugh ME, Jyonouchi S, Sullivan KE, Burroughs L, Skoda-Smith S, Haight AE, Tumlin AG, Quigg TC, Taylor C, Dávila Saldaña BJ, Keller MD, Seroogy CM, Desantes KB, Petrovic A, Leiding JW, Shyr DC, Decaluwe H, Teira P, Gillio AP, Knutsen AP, Moore TB, Kletzel M, Craddock JA, Aquino V, Davis JH, Yu LC, Cuvelier GDE, Bednarski JJ, Goldman FD, Kang EM, Shereck E, Porteus MH, Connelly JA, Fleisher TA, Malech HL, Shearer WT, Szabolcs P, Thakar MS, Vander Lugt MT, Heimall J, Yin Z, Pulsipher MA, Pai SY, Kohn DB, Puck JM, Cowan MJ, O'Reilly RJ, Notarangelo LD. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery. Blood. 2018 10 25;132(17):1737-1749. PMCID: PMC6202916
154. Dvorak CC, Haddad E, Buckley RH, Cowan MJ, Logan B, Griffith LM, Kohn DB, Pai SY, Notarangelo L, Shearer W, Prockop S, Kapoor N, Heimall J, Chaudhury S, Shyr D, Chandra S, Cuvelier G, Moore T, Shenoy S, Goldman F, Smith AR, Sunkersett G, Vander Lugt M, Caywood E, Quigg T, Torgerson T, Chandrakasan S, Craddock J, Dávila Saldaña BJ, Gillio A, Shereck E, Aquino V, DeSantes K, Knutsen A, Thakar M, Yu L, Puck JM. The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018). J Allergy Clin Immunol. 2019 01;143(1):405-407. PMCID: PMC6322970
155. Mangurian C, Scalchunes C, Yoo J, Logan B, Henderson T, Iyengar S, Smith H, Cowan MJ. Psychosocial services for primary immunodeficiency disorder families during hematopoietic cell transplantation: A descriptive study. Palliat Support Care. 2019 08;17(4):409-414. PMCID: PMC6422770
156. Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman OF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Parameswaran V, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Confer DL, Shaw BE. Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors. Haematologica. 2019 04;104(4):844-854. PMCID: PMC6442962
157. Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Bunin NJ, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Shaw BE, Confer DL. Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study. Biol Blood Marrow Transplant. 2019 04;25(4):699-711. PMCID: PMC6453753
158. Thakar MS, Broglie L, Logan B, Artz A, Bunin N, Burroughs LM, Fretham C, Jacobsohn DA, Loren AW, Kurtzberg J, Martinez CA, Mineishi S, Nelson AS, Woolfrey A, Pasquini MC, Sorror ML. The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. Blood. 2019 02 14;133(7):754-762. PMCID: PMC6376282
159. Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Ball ED, Bolwell BJ, Bunin NJ, Cheerva A, Delgado DC, Dvorak CC, Gillio AP, Hahn TE, Hale GA, Haight AE, Hayes-Lattin BM, Kasow KA, Linenberger M, Magalhaes-Silverman M, Mori S, Prasad VK, Quigg TC, Sahdev I, Schriber JR, Shenoy S, Tse WT, Yanik GA, Navarro WH, Horowitz MM, Confer DL, Shaw BE, Switzer GE. Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results. Biol Blood Marrow Transplant. 2019 05;25(5):955-964. PMCID: PMC6511296
160. Sparapani R, Logan BR, McCulloch RE, Laud PW. Nonparametric competing risks analysis using Bayesian Additive Regression Trees. Stat Methods Med Res. 2020 01;29(1):57-77. PMCID: PMC6954340
161. Prokopishyn NL, Logan BR, Kiefer DM, Sees JA, Chitphakdithai P, Ahmed IA, Anderlini PN, Beitinjaneh AM, Bredeson C, Cerny J, Chhabra S, Daly A, Diaz MA, Farhadfar N, Frangoul HA, Ganguly S, Gastineau DA, Gergis U, Hale GA, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Murthy HS, Norkin M, Olsson RF, Papari M, Savani BN, Szer J, Waller EK, Wirk B, Yared JA, Pulsipher MA, Shah NN, Switzer GE, O'Donnell PV, Confer DL, Shaw BE. The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time. Biol Blood Marrow Transplant. 2019 07;25(7):1325-1330. PMCID: PMC6615955
162. Liu N, Liu Y, Logan B, Xu Z, Tang J, Wang Y. Learning the Dynamic Treatment Regimes from Medical Registry Data through Deep Q-network. Sci Rep. 2019 02 06;9(1):1495. PMCID: PMC6365640
163. Bolaños-Meade J, Reshef R, Fraser R, Fei M, Abhyankar S, Al-Kadhimi Z, Alousi AM, Antin JH, Arai S, Bickett K, Chen YB, Damon LE, Efebera YA, Geller NL, Giralt SA, Hari P, Holtan SG, Horowitz MM, Jacobsohn DA, Jones RJ, Liesveld JL, Logan BR, MacMillan ML, Mielcarek M, Noel P, Pidala J, Porter DL, Pusic I, Sobecks R, Solomon SR, Weisdorf DJ, Wu J, Pasquini MC, Koreth J. Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203). Lancet Haematol. 2019 Mar;6(3):e132-e143. PMCID: PMC6503965
164. Schmainda KM, Prah MA, Hu LS, Quarles CC, Semmineh N, Rand SD, Connelly JM, Anderies B, Zhou Y, Liu Y, Logan B, Stokes A, Baird G, Boxerman JL. Moving Toward a Consensus DSC-MRI Protocol: Validation of a Low-Flip Angle Single-Dose Option as a Reference Standard for Brain Tumors. AJNR Am J Neuroradiol. 2019 04;40(4):626-633. PMCID: PMC6461489
165. Wiener L, Hoag JA, Pelletier W, Shah NN, Shaw BE, Pulsipher MA, Bruce J, Bader P, Willasch AM, Dalissier A, Guilcher G, Anthias C, Confer DL, Sees JA, Logan B, Switzer GE. Transplant center practices for psychosocial assessment and management of pediatric hematopoietic stem cell donors. Bone Marrow Transplant. 2019 11;54(11):1780-1788. PMCID: PMC6961459
166. Hurley CK, Spellman S, Dehn J, Barker JN, Devine S, Fernandez-Vina M, Gautreaux M, Logan B, Maiers M, Mueller C, Perales MA, Yu N, Pidala J. Regarding "Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study". Biol Blood Marrow Transplant. 2019 08;25(8):e268-e269.
167. Ambinder RF, Wu J, Logan B, Durand CM, Shields R, Popat UR, Little RF, McMahon DK, Cyktor J, Mellors JW, Ayala E, Kaplan LD, Noy A, Jones RJ, Howard A, Forman SJ, Porter D, Arce-Lara C, Shaughnessy P, Sproat L, Hashmi SK, Mendizabal AM, Horowitz MM, Navarro WH, Alvarnas JC. Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial. Biol Blood Marrow Transplant. 2019 11;25(11):2160-2166. PMCID: PMC6907401
168. Waller EK, Logan BR, Fei M, Lee SJ, Confer D, Howard A, Chandrakasan S, Anasetti C, Fernando SM, Giver CR. Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF-mobilized stem cell transplantation. Blood Adv. 2019 08 13;3(15):2250-2263. PMCID: PMC6693008
169. Marsh RA, Leiding JW, Logan BR, Griffith LM, Arnold DE, Haddad E, Falcone EL, Yin Z, Patel K, Arbuckle E, Bleesing JJ, Sullivan KE, Heimall J, Burroughs LM, Skoda-Smith S, Chandrakasan S, Yu LC, Oshrine BR, Cuvelier GDE, Thakar MS, Chen K, Teira P, Shenoy S, Phelan R, Forbes LR, Chellapandian D, Dávila Saldaña BJ, Shah AJ, Weinacht KG, Joshi A, Boulad F, Quigg TC, Dvorak CC, Grossman D, Torgerson T, Graham P, Prasad V, Knutsen A, Chong H, Miller H, de la Morena MT, DeSantes K, Cowan MJ, Notarangelo LD, Kohn DB, Stenger E, Pai SY, Routes JM, Puck JM, Kapoor N, Pulsipher MA, Malech HL, Parikh S, Kang EM, submitted on behalf of the Primary Immune Deficiency Treatment Consortium. Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT. J Clin Immunol. 2019 10;39(7):653-667. PMCID: PMC6754755
170. Pidala J, Martens M, Anasetti C, Carreras J, Horowitz M, Lee SJ, Antin J, Cutler C, Logan B. Factors Associated With Successful Discontinuation of Immune Suppression After Allogeneic Hematopoietic Cell Transplantation. JAMA Oncol. 2020 Jan 01;6(1):e192974. PMCID: PMC6763979
171. Zinter MS, Logan BR, Fretham C, Sapru A, Abraham A, Aljurf MD, Arnold SD, Artz A, Auletta JJ, Chhabra S, Copelan E, Duncan C, Gale RP, Guinan E, Hematti P, Keating AK, Marks DI, Olsson R, Savani BN, Ustun C, Williams KM, Pasquini MC, Dvorak CC. Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries. Biol Blood Marrow Transplant. 2020 02;26(2):333-342. PMCID: PMC6943183
172. Shah AJ, Sokolic R, Logan B, Yin Z, Iyengar S, Scalchunes C, Mangurian C, Albert M, Cowan MJ. Quality of Life of Patients with Wiskott Aldrich Syndrome and X-Linked Thrombocytopenia: a Study of the Primary Immune Deficiency Consortium (PIDTC), Immune Deficiency Foundation, and the Wiskott-Aldrich Foundation. J Clin Immunol. 2019 11;39(8):786-794. PMCID: PMC7385986
173. Martens MJ, Logan BR. Group sequential tests for treatment effect on survival and cumulative incidence at a fixed time point. Lifetime Data Anal. 2020 07;26(3):603-623. PMCID: PMC7365590
174. Pidala J, Hamadani M, Dawson P, Martens M, Alousi AM, Jagasia M, Efebera YA, Chhabra S, Pusic I, Holtan SG, Ferrara JLM, Levine JE, Mielcarek M, Anasetti C, Antin JH, Bolaños-Meade J, Howard A, Logan BR, Leifer ES, Pritchard TS, Horowitz MM, MacMillan ML. Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial. Blood. 2020 01 09;135(2):97-107. PMCID: PMC6952830
175. Majhail NS, Mau LW, Chitphakdithai P, Denzen EM, Joffe S, Lee SJ, LeMaistre CF, Loberiza F, Parsons SK, Repaczki-Jones R, Robinett P, Douglas Rizzo J, Murphy E, Logan B, Le-Rademacher J. Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults. Bone Marrow Transplant. 2020 05;55(5):906-917. PMCID: PMC7202970
176. Giralt S, Costa LJ, Maloney D, Krishnan A, Fei M, Antin JH, Brunstein C, Geller N, Goodman S, Hari P, Logan B, Lowsky R, Qazilbash MH, Sahebi F, Somlo G, Rowley S, Vogl DT, Vesole DH, Pasquini M, Stadtmauer E. Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 Trial. Biol Blood Marrow Transplant. 2020 04;26(4):798-804. PMCID: PMC7198329
177. Ballen K, Logan BR, Chitphakdithai P, Kuxhausen M, Spellman SR, Adams A, Drexler RJ, Duffy M, Kemp A, King R, Babic A, Delaney C, Karanes C, Kurtzberg J, Petz L, Scaradavou A, Shpall EJ, Smith C, Confer DL, Miller JP. Unlicensed Umbilical Cord Blood Units Provide a Safe and Effective Graft Source for a Diverse Population: A Study of 2456 Umbilical Cord Blood Recipients. Biol Blood Marrow Transplant. 2020 04;26(4):745-757. PMCID: PMC7198366
178. Knight JM, Rizzo JD, Wang T, He N, Logan BR, Spellman SR, Lee SJ, Verneris MR, Arevalo JMG, Cole SW. Molecular Correlates of Socioeconomic Status and Clinical Outcomes Following Hematopoietic Cell Transplantation for Leukemia. JNCI Cancer Spectr. 2019 Dec;3(4):pkz073. PMCID: PMC6859844
179. Atallah E, Logan B, Chen M, Cutler C, Deeg J, Jacoby M, Champlin R, Nishihori T, Confer D, Gajewski J, Farnia S, Greenberg P, Warlick E, Weisdorf D, Saber W, Horowitz MM, Rizzo JD. Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development Study. JAMA Oncol. 2020 04 01;6(4):486-493. PMCID: PMC6990739
180. Hourigan CS, Dillon LW, Gui G, Logan BR, Fei M, Ghannam J, Li Y, Licon A, Alyea EP, Bashey A, Deeg HJ, Devine SM, Fernandez HF, Giralt S, Hamadani M, Howard A, Maziarz RT, Porter DL, Scott BL, Warlick ED, Pasquini MC, Horwitz ME. Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease. J Clin Oncol. 2020 04 20;38(12):1273-1283. PMCID: PMC7164487
181. Dorsey MJ, Wright NAM, Chaimowitz NS, Dávila Saldaña BJ, Miller H, Keller MD, Thakar MS, Shah AJ, Abu-Arja R, Andolina J, Aquino V, Barnum JL, Bednarski JJ, Bhatia M, Bonilla FA, Butte MJ, Bunin NJ, Chandra S, Chaudhury S, Chen K, Chong H, Cuvelier GDE, Dalal J, DeFelice ML, DeSantes KB, Forbes LR, Gillio A, Goldman F, Joshi AY, Kapoor N, Knutsen AP, Kobrynski L, Lieberman JA, Leiding JW, Oshrine B, Patel KP, Prockop S, Quigg TC, Quinones R, Schultz KR, Seroogy C, Shyr D, Siegel S, Smith AR, Torgerson TR, Vander Lugt MT, Yu LC, Cowan MJ, Buckley RH, Dvorak CC, Griffith LM, Haddad E, Kohn DB, Logan B, Notarangelo LD, Pai SY, Puck J, Pulsipher MA, Heimall J. Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers Journal of Clinical Immunology. 2020.
182. Knight JM, Rizzo JD, Hari P, Pasquini MC, Giles KE, D'Souza A, Logan BR, Hamadani M, Chhabra S, Dhakal B, Shah N, Sriram D, Horowitz MM, Cole SW. Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial. Blood Adv. 2020 02 11;4(3):467-476. PMCID: PMC7013267
183. Hsu JW, Shaw BE, Kim S, Logan BR, Sees JA, Confer DL, Pulsipher MA, Shah N, Switzer GE, Abidi MH, Ahmed IA, Anderlini PN, Bredeson C, Chhabra S, Dandoy CE, Diaz MA, Farhadfar N, Ganguly S, Gergis U, Hale GA, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Murthy HS, Olsson RF, Savani BN, Schears R, Seo S, Solh M, Spitzer T, Steinberg A, Sugrue M, Warkentin P, Wingard JR. Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors. Biol Blood Marrow Transplant. 2020 06;26(6):1210-1217. PMCID: PMC7347029
184. Farhadfar N, Hsu JW, Logan BR, Sees JA, Chitphakdithai P, Sugrue MW, Abdel-Azim H, Anderlini PN, Bredeson C, Chhabra S, Diaz MA, Ganguly S, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Lynch DK, Murthy HS, Olsson RF, Papari M, Przepiorka D, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Yared JA, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR. Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield. Blood Adv. 2020 02 25;4(4):706-716. PMCID: PMC7042992
185. Epperla N, Li A, Logan B, Fretham C, Chhabra S, Aljurf M, Chee L, Copelan E, Freytes CO, Hematti P, Lazarus HM, Litzow M, Nishihori T, Olsson RF, Prestidge T, Saber W, Wirk B, Yared JA, Loren A, Pasquini M. Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy. Br J Haematol. 2020 06;189(6):1171-1181. PMCID: PMC7726817
186. Seftel MD, Kuxhausen M, Burns L, Chitphakdithai P, Confer D, Kiefer D, Lee S, Logan B, O'Donnell P, Pulsipher M, Shah NN, Switzer G, Shaw BE. Clonal Hematopoiesis in Related Allogeneic Transplant Donors: Implications for Screening and Management. Biol Blood Marrow Transplant. 2020 06;26(6):e142-e144. PMCID: PMC7440392
187. Chan AY, Leiding JW, Liu X, Logan BR, Burroughs LM, Allenspach EJ, Skoda-Smith S, Uzel G, Notarangelo LD, Slatter M, Gennery AR, Smith AR, Pai SY, Jordan MB, Marsh RA, Cowan MJ, Dvorak CC, Craddock JA, Prockop SE, Chandrakasan S, Kapoor N, Buckley RH, Parikh S, Chellapandian D, Oshrine BR, Bednarski JJ, Cooper MA, Shenoy S, Davila Saldana BJ, Forbes LR, Martinez C, Haddad E, Shyr DC, Chen K, Sullivan KE, Heimall J, Wright N, Bhatia M, Cuvelier GDE, Goldman FD, Meyts I, Miller HK, Seidel MG, Vander Lugt MT, Bacchetta R, Weinacht KG, Andolina JR, Caywood E, Chong H, de la Morena MT, Aquino VM, Shereck E, Walter JE, Dorsey MJ, Seroogy CM, Griffith LM, Kohn DB, Puck JM, Pulsipher MA, Torgerson TR. Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey. Front Immunol. 2020;11:239. PMCID: PMC7046837
188. Burroughs LM, Petrovic A, Brazauskas R, Liu X, Griffith LM, Ochs HD, Bleesing JJ, Edwards S, Dvorak CC, Chaudhury S, Prockop SE, Quinones R, Goldman FD, Quigg TC, Chandrakasan S, Smith AR, Parikh S, Dávila Saldaña BJ, Thakar MS, Phelan R, Shenoy S, Forbes LR, Martinez C, Chellapandian D, Shereck E, Miller HK, Kapoor N, Barnum JL, Chong H, Shyr DC, Chen K, Abu-Arja R, Shah AJ, Weinacht KG, Moore TB, Joshi A, DeSantes KB, Gillio AP, Cuvelier GDE, Keller MD, Rozmus J, Torgerson T, Pulsipher MA, Haddad E, Sullivan KE, Logan BR, Kohn DB, Puck JM, Notarangelo LD, Pai SY, Rawlings DJ, Cowan MJ. Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report. Blood. 2020 06 04;135(23):2094-2105. PMCID: PMC7273831
189. Farhadfar N, Murthy HS, Logan BR, Sees JA, Ayas M, Battiwalla M, Beitinjaneh AM, Chhabra S, Diaz MA, Engles K, Frangoul H, Ganguly S, Gergis U, Kamani NR, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Norkin M, O' Donnell PV, Olsson RF, Rossmann S, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Sugrue M, Yared JA, Linenberger M, Schwartz J, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR. Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysis. Bone Marrow Transplant. 2020 11;55(11):2121-2131. PMCID: PMC7606543
190. Farhadfar N, Murthy HS, Logan BR, Sees JA, Ayas M, Battiwalla M, Beitinjaneh AM, Chhabra S, Diaz MA, Engles K, Frangoul H, Ganguly S, Gergis U, Kamani NR, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Norkin M, O' Donnell PV, Olsson RF, Rossmann S, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Sugrue M, Yared JA, Linenberger M, Schwartz J, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR. Correction: Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysis. Bone Marrow Transplant. 2021 Feb;56(2):522. PMCID: PMC7722110
191. Marsh RA, Leiding JW, Logan BR, Griffith LM, Arnold DE, Haddad E, Falcone EL, Yin Z, Patel K, Arbuckle E, Bleesing JJ, Sullivan KE, Heimall J, Burroughs LM, Skoda-Smith S, Chandrakasan S, Yu LC, Oshrine BR, Cuvelier GDE, Thakar MS, Chen K, Teira P, Shenoy S, Phelan R, Forbes LR, Martinez C, Chellapandian D, Dávila Saldaña BJ, Shah AJ, Weinacht KG, Joshi A, Boulad F, Quigg TC, Dvorak CC, Grossman D, Torgerson T, Graham P, Prasad V, Knutsen A, Chong H, Miller H, de la Morena MT, DeSantes K, Cowan MJ, Notarangelo LD, Kohn DB, Stenger E, Pai SY, Routes JM, Puck JM, Kapoor N, Pulsipher MA, Malech HL, Parikh S, Kang EM, submitted on behalf of the Primary Immune Deficiency Treatment Consortium. Correction: Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT. J Clin Immunol. 2020 Nov;40(8):1211-1213.
192. Fuchs EJ, O'Donnell PV, Eapen M, Logan BR, Antin JH, Dawson P, Devine SM, Horowitz MM, Horwitz ME, Karanes C, Leifer E, Magenau JM, McGuirk JP, Morris LE, Rezvani AR, Jones RJ, Brunstein CG. Double unrelated umbilical cord blood versus HLA-haploidentical bone marrow transplantation (BMT CTN 1101). Blood. 2020 Aug 31.
193. Kim S, Logan B, Riches M, Chen M, Ahn KW. Statistical Methods for Time-Dependent Variables in Hematopoietic Cell Transplantation Studies. Transplant Cell Ther. 2021 02;27(2):125-132. PMCID: PMC8015678
194. Martens MJ, Logan BR. A unified approach to sample size and power determination for testing parameters in generalized linear and time-to-event regression models. Stat Med. 2021 02 28;40(5):1121-1132. PMCID: PMC8020892
195. Panch SR, Logan B, Sees JA, Bo-Subait S, Savani B, Shah NN, Hsu JW, Switzer G, Lazarus HM, Anderlini P, Hematti P, Confer D, Pulsipher MA, Shaw BE, Stroncek DF. Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell Donations. Transplant Cell Ther. 2021 06;27(6):503.e1-503.e8. PMCID: PMC8217152
196. Seftel MD, Chitphakdithai P, Miller JP, Kobusingye H, Logan BR, Linenberger M, Artz AS, Haight AE, Jacobsohn DA, Litzow MR, Magalhaes-Silverman M, Selby GB, Vusirikala M, Horowitz MM, Switzer GE, Confer DL, Shaw BE, Pulsipher MA. Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study. Transplant Cell Ther. 2021 04;27(4):352.e1-352.e5. PMCID: PMC8036235
197. Hsu JW, Farhadfar N, Murthy H, Logan BR, Bo-Subait S, Frey N, Goldstein SC, Horowitz MM, Lazarus H, Schwanke JD, Shah NN, Spellman SR, Switzer GE, Devine SM, Shaw BE, Wingard JR. The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic. Transplant Cell Ther. 2021 06;27(6):507-516. PMCID: PMC8217124
198. Wingard JR, Ahn KW, Dandoy C, Perales MA, Wood WA, Logan B, Riches M, Rizzo JD. COVID-19 and Hematopoietic Cell Transplantation Center-Specific Survival Analysis: Can We Adjust for the Impact of the Pandemic? Recommendations of the COVID-19 Task Force of the 2020 Center for International Blood and Marrow Transplantation Research Center Outcomes Forum. Transplant Cell Ther. 2021 07;27(7):533-539. PMCID: PMC8061634
199. Shaw BE, Jimenez-Jimenez AM, Burns LJ, Logan BR, Khimani F, Shaffer BC, Shah NN, Mussetter A, Tang XY, McCarty JM, Alavi A, Farhadfar N, Jamieson K, Hardy NM, Choe H, Ambinder RF, Anasetti C, Perales MA, Spellman SR, Howard A, Komanduri KV, Luznik L, Norkin M, Pidala JA, Ratanatharathorn V, Confer DL, Devine SM, Horowitz MM, Bolaños-Meade J. National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide. J Clin Oncol. 2021 Jun 20;39(18):1971-1982. PMCID: PMC8260905
200. Logan BR, Maiers MJ, Sparapani RA, Laud PW, Spellman SR, McCulloch RE, Shaw BE. Optimal Donor Selection for Hematopoietic Cell Transplantation Using Bayesian Machine Learning. JCO Clin Cancer Inform. 2021 05;5:494-507. PMCID: PMC8443829
201. Dillon LW, Gui G, Logan BR, Fei M, Ghannam J, Li Y, Licon A, Alyea EP, Bashey A, Devine SM, Fernandez HF, Giralt S, Hamadani M, Howard A, Maziarz RT, Porter DL, Warlick ED, Pasquini MC, Scott BL, Horwitz ME, Deeg HJ, Hourigan CS. Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic Syndrome. JCO Precis Oncol. 2021;5. PMCID: PMC8140814
202. Kim HT, Logan B, Weisdorf DJ. Novel Composite Endpoints after Allogeneic Hematopoietic Cell Transplantation. Transplant Cell Ther. 2021 08;27(8):650-657. PMCID: PMC8489461
 
Books, Chapters, and Reviews
1. Logan, B.R.: Solutions manual for "Statistics and Data Analysis: From Elementary to Intermediate", by Ajit C. Tamhane and Dorothy D. Dunlop, Upper Saddle River: Prentice-Hall, 2000.
2. Howard, D.H., Maiers, M., Gragert, L., Setterholm, M., Kollman, C., and Logan, B. The impact of cord blood inventory size on patient survival time and costs. In E. Meyer, A. Pope, Eds. Report on Establishing a National Cord Blood Stem Cell Bank Program. Washington, D.C.: National Academies Press, 2005.
3. Tamhane, A.C. and Logan, B.R. Multiple comparison procedures for dose-response studies. In Dose Finding in Drug Development, (Ed. N. Ting), Birkhauser/Springer-Verlag, 2006.
4. Logan, B.R. and Wang, T. Pseudo-value regression models. In Handbook of Survival Analysis, (Ed. J.P. Klein, H.C. Van Houwelingen, J.G. Ibrahim, T.H. Scheike), CRC Press, 2014.
5. Logan, B.R. Clinical Trials and Biostatistics. In ASCO-SEP: Medical Oncology Self-Evaluation Program, (Ed. M. Hensley, M.I. Milowsky, F.R. Appelbaum, J.T. Ruggiero), 5th Ed., American Society of Clinical Oncology, 2016.
 
Non-Refereed Journal Publications/Original Papers
1. Rowe, D.B. and Logan, B.R. An fMRI activation method using complex data. Proceedings of the International Society for Biomedical Imaging, #616, 2004.
2. Geliazkova, M.P. and Logan, B.R. Measuring the size of a region of activation in fMRI analysis. 2005 Proceedings of the American Statistical Association, Minneapolis, MN.
 
Abstracts
1. Uysal, N., Schapira, M.M., Brondino, M.J., Logan, B., Sidhu, J.K. A randomized clinical trial to test the effectiveness of risk communication on readiness to change among smokers in a primary care setting. ACCP Chest 2003 Meeting, Orlando, FL. Chest 2003; 124(45):230S.
2. Logan, B.R. and Rowe, D.B. (2004). A Comparison of fMRI activation thresholding methods. International Society for Magnetic Resonance in Medicine 2004 Meeting, Kyoto, Japan (05/2004). Proc. Intl. Soc. Magn. Reson. Med., 12, 1095.
3. Giralt, S., Logan, B., Zhang, M.J. et al. (2004). Non-ablative or reduced intensity conditioning regimen with volunteer unrelated donor progenitor cell transplantation. American Society of Hematologists Meeting, Blood, 104: 2751.
4. Wall, D., Wagner, J., Laughlin, M., Ballen, K., Staba, S., Chan, K.W., McGaha, O., Logan, B., et al. (2004). Higher cell dose and CD34+ content improves engraftment following unrelated donor cord blood transplantation (CBT): A report of the National Marrow Donor Program (NMDP) Cord Blood (CB) experience. American Society of Hematologists Meeting, Blood, 104: 975.
5. Tallman, M., Dewald, G., Lazarus, H., Gandham, S., Nelson, G., Logan, B., et al. (2004). Impact of cytogenetics on outcome of mismatched unrelated donor hematopoietic stem cell transplantation for adults with AML. American Society of Hematologists Meeting, Blood, 104: 830.
6. Howard, D.H., Meltzer, D., Kollman, C., Maiers, M., Logan, B., Gragert, L., Setterholm, M., Horowitz, M.M. (2005) Using cost-effectiveness analysis to design a national cord blood bank. Society for Medical Decision Making 2005 Meeting, San Francisco, CA (10/2005).
7. Pasquini, M.C., Logan, B.R., Verter, F., Horowitz, M.M., Nietfeld, J.J. (2005) The likelihood of hematopoietic stem cell transplantation (HCT) in the United States: Implications for umbilical cord blood storage. American Society of Hematologists Meeting, Blood, 106: 1330.
8. Pulsipher, M., Kurian, S., Leitman, S.F., Anderlini, P., Haagenson, M., Logan, B., et al. (2005) Unrelated-donor PBSC collection facilitated by the NMDP, 1999-2005: Efficacy and toxicities, serious unexpected events, and outcomes of standard vs. large volume collections. American Society of Hematologists Meeting, 106: 1965.
9. Eapen, M., Haagenson, M., Logan, B., et al. (2005) Use of peripheral blood grafts is associated with increased acute and chronic graft-versus-host disease without improved survival after unrelated donor transplantation. American Society of Hematologists Meeting, 106: 443.
10. Geliazkova, M.P. and Logan, B.R. (2006) ROC Analysis of spatial thresholding procedures in fMRI analysis. Submitted to Human Brain Mapping 2006, Abstract 619, Florence, Italy (06/2006).
11. Logan, B.R., Geliazkova, M.P., Laud, P.W., Rowe, D.B. (2007) A Bayesian spatial mixture model for fMRI analysis. Submitted to Human Brain Mapping 2007, Abstract 317, Chicago, IL (06/2007)
12. Alousi A, Weisdorf DJ, Logan BR, Meade JB, Goldstein SX, Ho VT, Hayes-Lattin B, Wingard JR, Horowitz MM, and Levine JE, BMT CTN 0302: A Phase II Randomized Trial Evaluating Etanercept, Mycophenolate Mofetil (MMF), Denileukin Diftitox, and Pentostatin in Combination with Corticosteroids in 180 Patients (pts) with Newly Diagnosed Acute Graft Vs. Host Disease (aGVHD), Blood (ASH Annual Meeting Abstracts), Nov 2008; 112: 55.
13. Navarro WH, Agovi MA, Logan B, Bacigalupo A, Ballen KK, Bolwell BJ, Frangoul H, Gupta V, Hahn T, Juckett M, Lazarus HM, Litzow MR, Liesveld J, Moreb J, Marks D, McCarthy PL, and Rizzo JD, Obesity Does Not Preclude Safe and Effective Myeloablative Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML) in Adults, Blood (ASH Annual Meeting Abstracts), Nov 2008; 112: 51.
14. Gupta V, Tallman MS, He W, Logan B, DiPersio JF, Bunjes DW, Weisdorf DJ. Comparable disease-free and overall survival after "well-matched" unrelated donor and matched sibling donor transplantation in acute myeloid leukemia with adverse risk karyotype in first Complete remission - a report from the Acute Leukemia Working Committee of the Centre for International Blood and Marrow Transplant Research. , Blood (ASH Annual Meeting Abstracts), Nov 2009; 114: 526.
15. Sabloff M, Chandy M,Wang Z, Logan B, Li C-K, Irfan SM, Eapen M, Walters MC. Bone marrow transplantation from HLA-identical sibling for Thalassemia, , Blood (ASH Annual Meeting Abstracts), Nov 2009; 114: 3361.
16. Horan, J Logan BR, Agovi M-A, Lazarus HM, Bacigalupo A, Ballen K, Martino R, Juckett MB, Khoury HJ, Bredeson C, Gupta V, Smith FO, Hale G, Carabasi M, McCarthy PL, Rizzo JD, Pasquini MC. Reducing the risk for transplant related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? , Blood (ASH Annual Meeting Abstracts), Nov 2009; 114: 649.
17. Barker CC, Agovi M-A, Logan B, Gupta V, Lazarus HM, Ballen KK, Hale GA, Frangoul H, Rizzo JD, Pasquini MC. Obesity adversely affects survival of pediatric patients with severe aplastic anemia after hematopoietic cell transplantation, , Blood (ASH Annual Meeting Abstracts), Nov 2009; 114: 652.